| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| MousePheno | abnormal prenatal growth/weight/body size | SUPT20HL1 KLF8 ABCA1 DZIP1L HEMGN ZMYM2 MCM4 CHD2 IRS1 SSR1 ITGA5 SLC12A5 GMPS FZR1 BMP8B DLC1 DST BRCA1 BRCA2 ARHGAP31 ANLN TONSL DLD AFDN KIF2A CPLANE1 CRAMP1 NOVA1 LIAS ZEB1 TCF20 B4GAT1 UBR4 CREBBP STRIP1 PIKFYVE CCNF SETD2 C2CD3 LATS2 NKX2-1 SH3PXD2A PAXIP1 PARD3 | 1.08e-06 | 1493 | 195 | 44 | MP:0004196 |
| MousePheno | prenatal growth retardation | SUPT20HL1 KLF8 ABCA1 ZMYM2 MCM4 CHD2 IRS1 SSR1 ITGA5 SLC12A5 FZR1 BMP8B DLC1 BRCA1 BRCA2 ANLN TONSL DLD KIF2A CPLANE1 LIAS ZEB1 TCF20 CREBBP STRIP1 SETD2 C2CD3 LATS2 SH3PXD2A PAXIP1 PARD3 | 1.24e-06 | 869 | 195 | 31 | MP:0010865 |
| MousePheno | increased T cell derived lymphoma incidence | 8.27e-06 | 53 | 195 | 7 | MP:0002024 | |
| MousePheno | granulomatous inflammation | 9.38e-06 | 36 | 195 | 6 | MP:0002500 | |
| MousePheno | increased thymus tumor incidence | 9.39e-06 | 54 | 195 | 7 | MP:0010365 | |
| MousePheno | abnormal embryonic growth/weight/body size | SUPT20HL1 KLF8 ABCA1 DZIP1L HEMGN ZMYM2 MCM4 SSR1 ITGA5 SLC12A5 GMPS FZR1 BMP8B DLC1 DST BRCA1 BRCA2 ARHGAP31 ANLN TONSL DLD AFDN KIF2A CPLANE1 CRAMP1 LIAS B4GAT1 UBR4 CREBBP STRIP1 PIKFYVE CCNF SETD2 C2CD3 LATS2 PAXIP1 PARD3 | 1.88e-05 | 1295 | 195 | 37 | MP:0002088 |
| MousePheno | embryonic growth retardation | SUPT20HL1 KLF8 ABCA1 ZMYM2 MCM4 SSR1 ITGA5 SLC12A5 FZR1 BMP8B DLC1 BRCA1 BRCA2 ANLN TONSL DLD KIF2A CPLANE1 LIAS CREBBP STRIP1 SETD2 C2CD3 LATS2 PAXIP1 PARD3 | 2.19e-05 | 763 | 195 | 26 | MP:0003984 |
| MousePheno | abnormal sternum morphology | MYF5 MYF6 MYOG TUBGCP2 BRCA2 KMT2A CPLANE1 FRAS1 ZEB1 SIK3 CREBBP TGFB2 SH3PXD2A | 6.04e-05 | 255 | 195 | 13 | MP:0000157 |
| MousePheno | perinatal lethality | MYF5 MYF6 ABCA1 MYOG RC3H1 SRRM4 MCM4 SSR1 SLC12A5 BRCA2 NRK GORAB KMT2A RABGEF1 KIF2A COL1A1 BAHCC1 FNDC3B ZEB1 NEDD4L B4GAT1 UBR4 SIK3 CREBBP TGFB2 PIKFYVE TGFB3 NKX2-1 SH3PXD2A ZNF516 GGA1 SLX4 | 8.96e-05 | 1130 | 195 | 32 | MP:0002081 |
| MousePheno | increased lymphoma incidence | 1.01e-04 | 164 | 195 | 10 | MP:0012431 | |
| MousePheno | abnormal heart atrium morphology | CHD2 DLC1 CPLANE1 CREBBP TGFB2 PIKFYVE LATS2 XIRP2 SH3PXD2A PARD3 NCF1C NCF1B | 1.01e-04 | 232 | 195 | 12 | MP:0003105 |
| MousePheno | chronic inflammation | 1.15e-04 | 79 | 195 | 7 | MP:0002499 | |
| MousePheno | increased mammary gland tumor incidence | 1.73e-04 | 38 | 195 | 5 | MP:0010299 | |
| Domain | DUF4592 | 2.12e-06 | 3 | 241 | 3 | IPR028030 | |
| Domain | DUF4592 | 2.12e-06 | 3 | 241 | 3 | PF15262 | |
| Domain | Basic | 8.41e-06 | 4 | 241 | 3 | IPR002546 | |
| Domain | BASIC | 8.41e-06 | 4 | 241 | 3 | SM00520 | |
| Domain | Basic | 8.41e-06 | 4 | 241 | 3 | PF01586 | |
| Domain | C2_dom | PIK3CD PLCL2 C2CD6 SYT13 RASAL2 UNC13B NEDD4L PCLO RPH3A C2CD3 | 5.49e-05 | 164 | 241 | 10 | IPR000008 |
| Domain | - | 1.32e-04 | 148 | 241 | 9 | 2.60.40.150 | |
| Domain | Actin-binding_Xin_repeat | 1.66e-04 | 2 | 241 | 2 | IPR012510 | |
| Domain | XIRP1/XIRP2 | 1.66e-04 | 2 | 241 | 2 | IPR030072 | |
| Domain | XIN | 1.66e-04 | 2 | 241 | 2 | PS51389 | |
| Domain | Xin | 1.66e-04 | 2 | 241 | 2 | PF08043 | |
| Domain | C2 | 3.03e-04 | 131 | 241 | 8 | PF00168 | |
| Domain | C2 | 4.10e-04 | 137 | 241 | 8 | SM00239 | |
| Domain | TGFb_propeptide | 4.34e-04 | 28 | 241 | 4 | PF00688 | |
| Domain | TGF-b_N | 4.34e-04 | 28 | 241 | 4 | IPR001111 | |
| Domain | TGF-beta | 4.93e-04 | 3 | 241 | 2 | IPR016319 | |
| Domain | C2 | 5.20e-04 | 142 | 241 | 8 | PS50004 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SYNRG CEP85L SIPA1L3 IRS1 GAB2 NSD3 NEK1 DLC1 DST ANLN KMT2A AFDN RABGEF1 KIF2A PPIP5K2 DOCK6 RASAL2 TCF20 NEDD4L POTEF RANBP3 SIK3 C2CD3 SH3PXD2A ELMO2 CGNL1 MTREX PARD3 CDC25B AHNAK2 | 2.48e-12 | 861 | 257 | 30 | 36931259 |
| Pubmed | MIS18BP1 ZMYM2 PHF8 BRCA1 BRCA2 KIF2A MGA TCF20 POLDIP3 CREBBP ZNF516 TPX2 PAXIP1 RBM6 SLX4 | 1.35e-10 | 222 | 257 | 15 | 37071664 | |
| Pubmed | GPRASP1 SIPA1L3 TRPC4 ZMYM2 SYNPO SLC12A5 CNTNAP5 DST G3BP2 AFDN RABGEF1 KIF2A MGA RASAL2 DMXL2 ZEB1 TCF20 NEDD4L UBR4 SIK3 RPH3A STRIP1 AGO1 ZNF516 PRDX1 QSER1 PARD3 | 3.79e-09 | 963 | 257 | 27 | 28671696 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MIS18BP1 SRP68 SRPK1 MCM4 CHD2 SSR4 PHF8 LARP4 GMPS DST ANLN UTP20 AFDN KIF2A MGA DYNC1I2 RASAL2 TTF2 FNDC3B CCDC22 TCF20 POLDIP3 UBR4 DOCK10 LYAR CREBBP POLR3A KIF20A PRDX1 MTREX PARD3 AHNAK2 | 7.65e-09 | 1353 | 257 | 32 | 29467282 |
| Pubmed | LIN7C SIPA1L3 TUBGCP2 DST AFDN RABGEF1 KIF2A DOCK6 RASAL2 TTF2 KIAA1549 STRIP1 ERLIN2 LATS2 MAP1S SH3PXD2A MTREX PARD3 | 7.70e-09 | 446 | 257 | 18 | 24255178 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SYNRG SIPA1L3 IRS1 ITGA5 STK11IP NSD3 FZR1 BMP8B DST PIK3CD DOCK6 CRAMP1 COL1A1 BAHCC1 UNC13B FRAS1 UBR4 PIKFYVE MST1R C2CD3 LATS2 MAP1S ZNF827 SLC25A39 ZNF516 PAXIP1 GGA1 AHNAK2 | 1.69e-08 | 1105 | 257 | 28 | 35748872 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | SYNRG MIS18BP1 ZMYM2 TUBGCP2 POTEE BRCA2 TONSL DLD CASP8AP2 POLDIP3 VPS50 CREBBP PIKFYVE SETD2 ZNF516 RBM6 CGNL1 POTEI MTREX SLX4 | 1.96e-08 | 588 | 257 | 20 | 38580884 |
| Pubmed | DNAJB12 LIN7C SIPA1L3 ZMYM2 SRP68 SRPK1 CHD2 SSR1 NSD3 POTEE CRACD DST BRCA1 ANLN GORAB INTS15 GOLIM4 KMT2A UTP20 AFDN CDYL KIF2A FNDC3B CCDC137 SCAF8 LYAR STRIP1 SETD2 CRACDL TPX2 RBM6 MTREX PARD3 | 2.36e-08 | 1497 | 257 | 33 | 31527615 | |
| Pubmed | SYNRG SRP68 PHF8 NSD3 NEK1 ANLN KMT2A AFDN MGA TTF2 CCDC22 TCF20 RANBP3 CREBBP SETD2 PRDX1 TPX2 QSER1 PARD3 | 3.42e-08 | 549 | 257 | 19 | 38280479 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SYNRG ZMYM2 MCM4 PHF8 ANLN KIAA1958 KMT2A UTP20 AFDN DYNC1I2 ZEB1 TCF20 SCAF8 STRIP1 SETD2 MAP1S STC2 ZNF516 GZMB TPX2 RBM6 PARD3 | 8.95e-08 | 774 | 257 | 22 | 15302935 |
| Pubmed | KLF8 RC3H1 ZMYM2 SRP68 PHF8 LARP4 DST BRCA1 G3BP2 KMT2A DLD MGA ZEB1 TCF20 SCAF8 POLDIP3 UBR4 RFXAP CREBBP CCNA2 ERLIN2 YAF2 AGO1 TTC31 ZNF516 TPX2 PAXIP1 RBM6 FOXP1 QSER1 SLX4 | 9.33e-08 | 1429 | 257 | 31 | 35140242 | |
| Pubmed | SRPK1 SSR4 DST TONSL KMT2A AFDN KIF2A PPIP5K2 RASAL2 FNDC3B DMXL2 FRAS1 SCAF8 DOCK10 SIK3 POLR3A ELMO2 QSER1 MTREX CDC25B | 1.00e-07 | 650 | 257 | 20 | 38777146 | |
| Pubmed | 1.00e-07 | 7 | 257 | 4 | 14517256 | ||
| Pubmed | DNAJB12 SRP68 TUBGCP2 LARP4 GPKOW ANLN PPIP5K2 MGA CCDC22 TCF20 SCAF8 POLDIP3 VPS50 RNF213 FNDC3A STRIP1 PIKFYVE SETD2 ERLIN2 TPX2 QSER1 | 1.56e-07 | 733 | 257 | 21 | 34672954 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | MIS18BP1 ZMYM2 CHD2 SYNPO PHF8 GPKOW NSD3 BRCA1 ANLN KMT2A CDYL MGA TCF20 LYAR RFXAP KIF20A NKX2-1 TPX2 QSER1 | 1.67e-07 | 608 | 257 | 19 | 36089195 |
| Pubmed | SIPA1L3 SRP68 SYNPO SLC12A5 CRACD DST TTC7B G3BP2 KMT2A DLD AFDN KIF2A RASAL2 DMXL2 NEDD4L PCLO KIAA1549 RPH3A STRIP1 SLC44A1 ERLIN2 AGO1 MAP1S CRACDL LGI3 PRDX1 GKAP1 PLXNA4 KNDC1 CGNL1 | 3.15e-07 | 1431 | 257 | 30 | 37142655 | |
| Pubmed | 3.99e-07 | 3 | 257 | 3 | 8391976 | ||
| Pubmed | 3.99e-07 | 3 | 257 | 3 | 22729394 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | SYNRG MIS18BP1 CEP85L SIPA1L3 TUBGCP2 PHF8 BRCA2 DLD AFDN PPIP5K2 CPLANE1 MGA DYNC1I2 TTF2 CCDC22 SIK3 LYAR C2CD3 AGO1 ELMO2 CGNL1 GGA1 | 4.66e-07 | 853 | 257 | 22 | 28718761 |
| Pubmed | SRRM4 SYNPO DST ARHGAP31 PPIP5K2 DOCK6 CRAMP1 SYT13 CASP8AP2 VPS50 KIAA1549 FNDC3A SIK3 ZNF516 CNTNAP2 EFR3B MTREX | 5.15e-07 | 529 | 257 | 17 | 14621295 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ZMYM2 MCM4 GPKOW NSD3 TASOR2 BRCA1 BRCA2 ANLN KMT2A AFDN SPATA22 MGA CCDC137 TCF20 POLDIP3 LYAR FANCM SETD2 PRDX1 TPX2 RBM6 QSER1 SLX4 | 8.08e-07 | 954 | 257 | 23 | 36373674 |
| Pubmed | PHF8 LARP4 TASOR2 POTEE G3BP2 KIF2A DOCK6 ACP7 POLDIP3 PCLO TGFB2 SETD2 AGO1 RBM6 MTREX NCF1C | 1.07e-06 | 496 | 257 | 16 | 31343991 | |
| Pubmed | XIRP1 SRPK1 DST TTC7B GORAB CRAMP1 TCF20 UBR4 PIKFYVE AGO1 XIRP2 | 1.48e-06 | 233 | 257 | 11 | 37704626 | |
| Pubmed | Neuronal control of myogenic regulatory factor accumulation in fetal muscle. | 1.59e-06 | 4 | 257 | 3 | 17295338 | |
| Pubmed | The myoD gene family: nodal point during specification of the muscle cell lineage. | 1.59e-06 | 4 | 257 | 3 | 1846704 | |
| Pubmed | Early skeletal muscle development proceeds normally in parthenogenetic mouse embryos. | 1.59e-06 | 4 | 257 | 3 | 8293880 | |
| Pubmed | Skeletal muscle precursors in mouse esophagus are determined during early fetal development. | 1.59e-06 | 4 | 257 | 3 | 10974667 | |
| Pubmed | Developmental patterns in the expression of Myf5, MyoD, myogenin, and MRF4 during myogenesis. | 1.59e-06 | 4 | 257 | 3 | 1911647 | |
| Pubmed | Somite subdomains, muscle cell origins, and the four muscle regulatory factor proteins. | 1.59e-06 | 4 | 257 | 3 | 7929574 | |
| Pubmed | 1.59e-06 | 4 | 257 | 3 | 10898959 | ||
| Pubmed | 1.59e-06 | 4 | 257 | 3 | 10733231 | ||
| Pubmed | 1.59e-06 | 4 | 257 | 3 | 10635459 | ||
| Pubmed | 1.59e-06 | 4 | 257 | 3 | 16614355 | ||
| Pubmed | BRCA1 BRCA2 ANLN TONSL KIF2A MGA MUL1 ZEB1 TCF20 FANCM CREBBP SETD2 ZNF827 TPX2 SLX4 | 1.69e-06 | 453 | 257 | 15 | 29656893 | |
| Pubmed | MIS18BP1 SRP68 SSR1 NSD3 DST BRCA1 ANLN TONSL KMT2A CDYL CCDC22 CREBBP CCNA2 KIF20A C2CD3 ZNF516 TPX2 PAXIP1 | 1.78e-06 | 645 | 257 | 18 | 25281560 | |
| Pubmed | SRP68 SRPK1 MCM4 CHD2 LARP4 TASOR2 GMPS DST KMT2A DLD UTP20 AFDN TCF20 POLDIP3 UBR4 RBM6 MTREX XPO7 | 2.12e-06 | 653 | 257 | 18 | 22586326 | |
| Pubmed | DNAJB12 MIS18BP1 MCM4 CHD2 PHF8 GPKOW NSD3 GMPS KMT2A CASP8AP2 TCF20 POLDIP3 UBR4 RNF213 LYAR CREBBP POLR3A CCNA2 SETD2 TPX2 QSER1 MTREX XPO7 | 2.25e-06 | 1014 | 257 | 23 | 32416067 | |
| Pubmed | 3.94e-06 | 5 | 257 | 3 | 10673337 | ||
| Pubmed | Mrf4 determines skeletal muscle identity in Myf5:Myod double-mutant mice. | 3.94e-06 | 5 | 257 | 3 | 15386014 | |
| Pubmed | 3.94e-06 | 5 | 257 | 3 | 9268580 | ||
| Pubmed | Myogenic regulatory factors transactivate the Tceal7 gene and modulate muscle differentiation. | 3.94e-06 | 5 | 257 | 3 | 20307260 | |
| Pubmed | 3.94e-06 | 5 | 257 | 3 | 38244928 | ||
| Pubmed | 3.94e-06 | 5 | 257 | 3 | 8627340 | ||
| Pubmed | Embryonic founders of adult muscle stem cells are primed by the determination gene Mrf4. | 3.94e-06 | 5 | 257 | 3 | 23623977 | |
| Pubmed | Expression of myotonic dystrophy protein kinase gene during in vivo and in vitro mouse myogenesis. | 3.94e-06 | 5 | 257 | 3 | 9359635 | |
| Pubmed | 4.94e-06 | 16 | 257 | 4 | 36227576 | ||
| Pubmed | 4.94e-06 | 16 | 257 | 4 | 27760317 | ||
| Pubmed | ZMYM2 ANLN KMT2A MGA TCF20 RANBP3 CREBBP TPX2 PAXIP1 FOXP1 QSER1 | 5.69e-06 | 268 | 257 | 11 | 33640491 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DNAJB12 KLF8 CPAMD8 SIPA1L3 CHD2 SYNPO LARP4 ARMC2 TASOR2 GMPS PCYOX1L DOCK6 CRAMP1 ZFAND3 NEDD4L SCAF8 RNF213 CREBBP LATS2 ZNF827 SH3PXD2A KNDC1 RBM6 FOXP1 QSER1 PNPLA7 PARD3 XPO7 | 6.38e-06 | 1489 | 257 | 28 | 28611215 |
| Pubmed | Congenital asplenia in mice and humans with mutations in a Pbx/Nkx2-5/p15 module. | 7.42e-06 | 177 | 257 | 9 | 22560297 | |
| Pubmed | Chemokine-like receptor 1 regulates skeletal muscle cell myogenesis. | 7.85e-06 | 6 | 257 | 3 | 22460713 | |
| Pubmed | APC/C and SCF(cyclin F) Constitute a Reciprocal Feedback Circuit Controlling S-Phase Entry. | 7.85e-06 | 6 | 257 | 3 | 27653696 | |
| Pubmed | 7.85e-06 | 6 | 257 | 3 | 25830658 | ||
| Pubmed | 7.85e-06 | 6 | 257 | 3 | 2045411 | ||
| Pubmed | 7.85e-06 | 6 | 257 | 3 | 17325033 | ||
| Pubmed | 7.85e-06 | 6 | 257 | 3 | 10929709 | ||
| Pubmed | Kbtbd5 is regulated by MyoD and restricted to the myogenic lineage. | 7.85e-06 | 6 | 257 | 3 | 24361185 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | ZMYM2 SRP68 MCM4 CHD2 NSD3 TONSL KMT2A DYNC1I2 TCF20 POLDIP3 LYAR KIF20A TPX2 | 8.70e-06 | 394 | 257 | 13 | 27248496 |
| Pubmed | ZMYM2 SRP68 MCM4 TUBGCP2 GMPS BRCA1 ANLN G3BP2 KIAA1958 KMT2A KIF2A TTF2 ZFAND3 TCF20 POLDIP3 CREBBP ZNF516 PRDX1 TPX2 PAXIP1 FOXP1 QSER1 MTREX | 8.89e-06 | 1103 | 257 | 23 | 34189442 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | GMPS ANLN MGA BAHCC1 TTF2 ZEB1 TCF20 PCLO FAM90A1 CREBBP ZNF516 PAXIP1 FOXP1 | 9.69e-06 | 398 | 257 | 13 | 35016035 |
| Pubmed | 9.94e-06 | 39 | 257 | 5 | 30566624 | ||
| Pubmed | Muscle composition is regulated by a Lox-TGFβ feedback loop. | 1.03e-05 | 19 | 257 | 4 | 25715398 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | SRP68 CHD2 IRS1 PHF8 GMPS POTEE DST UTP20 LIAS PCLO UBR4 RNF213 PCDHA5 ZC2HC1C KDM4D GZMH PRDX1 PLXNA4 | 1.09e-05 | 736 | 257 | 18 | 29676528 |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | SRPK1 MCM4 SSR1 GPKOW FZR1 BRCA1 SPATA22 USH2A DYNC1I2 COL1A1 UNC13B DNHD1 LYAR FANCM CREBBP USP2 PAXIP1 | 1.20e-05 | 670 | 257 | 17 | 22990118 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ZMYM2 CHD2 PHF8 NSD3 DST BRCA1 TONSL KMT2A UTP20 CDYL MGA CASP8AP2 TTF2 TCF20 POLDIP3 LYAR FANCM RFXAP KIF20A SETD2 YAF2 TPX2 PAXIP1 QSER1 MTREX | 1.31e-05 | 1294 | 257 | 25 | 30804502 |
| Pubmed | Interaction network of human early embryonic transcription factors. | ZMYM2 KMT2A MGA BAHCC1 ZEB1 TCF20 CREBBP ZNF516 PAXIP1 FOXP1 QSER1 SLX4 | 1.36e-05 | 351 | 257 | 12 | 38297188 |
| Pubmed | Lineage restriction of the myogenic conversion factor myf-5 in the brain. | 1.37e-05 | 7 | 257 | 3 | 8575308 | |
| Pubmed | 1.37e-05 | 7 | 257 | 3 | 15276201 | ||
| Pubmed | 1.37e-05 | 7 | 257 | 3 | 18367555 | ||
| Pubmed | Immature adipocyte-derived exosomes inhibit expression of muscle differentiation markers. | 1.37e-05 | 7 | 257 | 3 | 33527775 | |
| Pubmed | KDM4A regulates myogenesis by demethylating H3K9me3 of myogenic regulatory factors. | 1.37e-05 | 7 | 257 | 3 | 34011940 | |
| Pubmed | Myogenin's functions do not overlap with those of MyoD or Myf-5 during mouse embryogenesis. | 1.37e-05 | 7 | 257 | 3 | 7589813 | |
| Pubmed | 1.37e-05 | 7 | 257 | 3 | 9418854 | ||
| Pubmed | 1.62e-05 | 149 | 257 | 8 | 22664934 | ||
| Pubmed | ZMYM2 SYNPO GAB2 NSD3 DST ARHGAP31 CPLANE1 MGA CASP8AP2 TCF20 NEDD4L SIK3 CREBBP CGNL1 | 1.80e-05 | 486 | 257 | 14 | 20936779 | |
| Pubmed | DNAJB12 ZMYM2 MCM4 TUBGCP2 GPKOW PCYOX1L GOLIM4 AFDN DYNC1I2 RANBP3 VPS50 MAP1S ELMO2 TPX2 MTREX | 2.12e-05 | 560 | 257 | 15 | 35241646 | |
| Pubmed | Overlapping functions of the myogenic bHLH genes MRF4 and MyoD revealed in double mutant mice. | 2.17e-05 | 8 | 257 | 3 | 9609818 | |
| Pubmed | 2.17e-05 | 8 | 257 | 3 | 18498113 | ||
| Pubmed | In vivo evidence for a bridging role of a collagen V subtype at the epidermis-dermis interface. | 2.17e-05 | 8 | 257 | 3 | 22437311 | |
| Pubmed | 2.17e-05 | 8 | 257 | 3 | 27939132 | ||
| Pubmed | 2.17e-05 | 8 | 257 | 3 | 9808779 | ||
| Pubmed | Development and patterning of rib primordia are dependent on associated musculature. | 2.17e-05 | 8 | 257 | 3 | 32768399 | |
| Pubmed | Persistent expression of MNF identifies myogenic stem cells in postnatal muscles. | 2.17e-05 | 8 | 257 | 3 | 9268575 | |
| Pubmed | Mouse Pop1 is required for muscle regeneration in adult skeletal muscle. | 2.17e-05 | 8 | 257 | 3 | 11839816 | |
| Pubmed | 2.17e-05 | 8 | 257 | 3 | 12475935 | ||
| Pubmed | Two cell lineages, myf5 and myf5-independent, participate in mouse skeletal myogenesis. | 2.17e-05 | 8 | 257 | 3 | 18331721 | |
| Pubmed | 2.17e-05 | 8 | 257 | 3 | 1374351 | ||
| Pubmed | 2.17e-05 | 8 | 257 | 3 | 18563556 | ||
| Pubmed | 2.17e-05 | 8 | 257 | 3 | 19843326 | ||
| Pubmed | CK2 kinase-mediated PHF8 phosphorylation controls TopBP1 stability to regulate DNA replication. | 2.17e-05 | 8 | 257 | 3 | 33010150 | |
| Pubmed | 2.17e-05 | 8 | 257 | 3 | 11201041 | ||
| Pubmed | 2.17e-05 | 8 | 257 | 3 | 10037786 | ||
| Pubmed | MyoD expression marks the onset of skeletal myogenesis in Myf-5 mutant mice. | 2.17e-05 | 8 | 257 | 3 | 7720554 | |
| Pubmed | Cdh1 regulates osteoblast function through an APC/C-independent modulation of Smurf1. | 2.17e-05 | 8 | 257 | 3 | 22152476 | |
| Pubmed | Expression of myogenic regulatory factors during the development of mouse tongue striated muscle. | 2.17e-05 | 8 | 257 | 3 | 10669094 | |
| Pubmed | 2.31e-05 | 23 | 257 | 4 | 20301575 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SYNRG ZMYM2 SRP68 MCM4 SSR4 GPKOW GMPS CRACD NEK1 DST KMT2A DLD TTF2 POLDIP3 RANBP3 SETD2 PRDX1 TPX2 CGNL1 AHNAK2 | 2.40e-05 | 934 | 257 | 20 | 33916271 |
| Pubmed | LIN7C ZMYM2 SRP68 CHD2 SSR1 ITGA5 GPKOW G3BP2 RASAL2 TCF20 UBR4 SIK3 CREBBP ZNF516 PAXIP1 AHNAK2 | 2.50e-05 | 638 | 257 | 16 | 31182584 | |
| Pubmed | SPEF2 DZIP1L SIPA1L3 CHD2 SYNPO TASOR2 POTEE DST BRCA1 KMT2A DLD PPIP5K2 DYNC1I2 BAHCC1 PCDHGB2 POTEF PCLO UBR4 C2CD3 ERLIN2 LATS2 SH3PXD2A PRDX1 PLXNA4 POTEI UTP14C | 2.84e-05 | 1442 | 257 | 26 | 35575683 | |
| Pubmed | 3.24e-05 | 9 | 257 | 3 | 31685980 | ||
| Interaction | YWHAH interactions | SYNRG CEP85L SIPA1L3 IRS1 GAB2 NSD3 NEK1 FZR1 DST ANLN KMT2A DLD AFDN RABGEF1 KIF2A PPIP5K2 DOCK6 RASAL2 TCF20 NEDD4L POTEF RANBP3 SIK3 CREBBP RPH3A CCNF MST1R C2CD3 YAF2 LATS2 SH3PXD2A CGNL1 MTREX PARD3 CDC25B AHNAK2 | 6.10e-08 | 1102 | 245 | 36 | int:YWHAH |
| Interaction | SNRNP40 interactions | MIS18BP1 RC3H1 SRPK1 MCM4 PHF8 NSD3 TASOR2 FZR1 BRCA1 BRCA2 ANLN G3BP2 TONSL KMT2A CDYL MGA CASP8AP2 TCF20 SCAF8 POLDIP3 KIF20A CCNF SETD2 RBM6 MTREX | 2.81e-07 | 637 | 245 | 25 | int:SNRNP40 |
| Interaction | MARK3 interactions | CEP85L RC3H1 EPB41L4A SSTR3 ANLN G3BP2 AFDN KIF2A STX7 POLDIP3 SIK3 AGO1 SH3PXD2A TPX2 PARD3 | 3.66e-07 | 246 | 245 | 15 | int:MARK3 |
| Interaction | ASF1A interactions | MCM4 NSD3 TASOR2 BRCA1 BRCA2 ANLN TONSL KMT2A MGA CASP8AP2 TCF20 POLR3A ZNF516 TPX2 QSER1 | 4.27e-07 | 249 | 245 | 15 | int:ASF1A |
| Interaction | YWHAG interactions | SYNRG CEP85L RC3H1 DZIP1L SIPA1L3 SRPK1 SYNPO IRS1 GAB2 CRACD NEK1 FZR1 DLC1 DST ANLN KMT2A DLD AFDN RABGEF1 KIF2A PPIP5K2 RASAL2 NEDD4L POTEF RANBP3 SIK3 CCNF MST1R C2CD3 LATS2 SH3PXD2A ELMO2 CGNL1 MTREX PARD3 CDC25B AHNAK2 | 4.40e-07 | 1248 | 245 | 37 | int:YWHAG |
| Interaction | LZTS2 interactions | MIS18BP1 CEP85L SIPA1L3 SYNPO EPB41L4A BRCA2 ANLN AFDN C2CD6 STX7 POLDIP3 CCDC187 ZC2HC1C FAM90A1 USP2 AGO1 LATS2 TTC31 CGNL1 PARD3 UTP14C | 1.32e-06 | 512 | 245 | 21 | int:LZTS2 |
| Interaction | MARK2 interactions | GPRASP1 CEP85L RC3H1 EPB41L4A SSTR3 GAB2 ANLN AFDN STX7 NEDD4L CREBBP AGO1 SH3PXD2A TPX2 PARD3 | 1.43e-06 | 274 | 245 | 15 | int:MARK2 |
| Interaction | USP7 interactions | NLRP11 POTEB3 GPRASP1 ABCA1 FSIP1 SRP68 SRPK1 MCM4 IRS1 SSR4 PHF8 EPB41L4A GMPS FZR1 DLC1 DST BRCA1 ANLN G3BP2 KIF2A DNHD1 ANKRD35 ZEB1 TCF20 NEDD4L DOCK10 CREBBP POTEC CCNF YAF2 SH3GLB1 TPX2 CNTNAP2 PLXNA4 CGNL1 MTREX UTP14C | 1.48e-06 | 1313 | 245 | 37 | int:USP7 |
| Interaction | AKR7L interactions | 2.60e-06 | 72 | 245 | 8 | int:AKR7L | |
| Interaction | SMAD2 interactions | ZMYM2 FAM161B BRCA1 BRCA2 AFDN COL1A1 ZEB1 NEDD4L SIK3 CREBBP CCNF USP2 YAF2 LATS2 PAXIP1 FOXP1 PARD3 | 5.29e-06 | 385 | 245 | 17 | int:SMAD2 |
| Interaction | TFDP1 interactions | 5.36e-06 | 133 | 245 | 10 | int:TFDP1 | |
| Interaction | POTED interactions | 7.04e-06 | 4 | 245 | 3 | int:POTED | |
| Interaction | PHLDB2 interactions | SYNPO EPB41L4A ANLN AFDN RASAL2 KIF20A LATS2 SH3PXD2A PARD3 CDC25B | 1.02e-05 | 143 | 245 | 10 | int:PHLDB2 |
| Interaction | TJP2 interactions | GJD2 SIPA1L3 SRPK1 MCM4 SSTR3 CRACD ANLN AFDN TTF2 KIF20A CCNF LATS2 TPX2 PARD3 | 1.25e-05 | 288 | 245 | 14 | int:TJP2 |
| Interaction | POTEC interactions | 1.40e-05 | 13 | 245 | 4 | int:POTEC | |
| Interaction | NCL interactions | RC3H1 SRP68 SRPK1 TASOR2 FZR1 BRCA1 BRCA2 ANLN G3BP2 KMT2A SYT13 ZEB1 POLDIP3 UBR4 FNDC3A LYAR FAM90A27P RFXAP KIF20A CCNF SETD2 AGO1 PNMA8A MTREX SLX4 | 1.53e-05 | 798 | 245 | 25 | int:NCL |
| Interaction | CYBRD1 interactions | 2.15e-05 | 47 | 245 | 6 | int:CYBRD1 | |
| Interaction | EFR3B interactions | 2.47e-05 | 71 | 245 | 7 | int:EFR3B | |
| Interaction | SFN interactions | SYNRG SIPA1L3 IRS1 GAB2 DST ANLN G3BP2 KMT2A RABGEF1 KIF2A RASAL2 NEDD4L RANBP3 ZC2HC1C SIK3 MST1R SH3PXD2A CGNL1 MTREX PARD3 CDC25B AHNAK2 | 4.09e-05 | 692 | 245 | 22 | int:SFN |
| Interaction | YWHAB interactions | SYNRG CEP85L RC3H1 SIPA1L3 IRS1 GAB2 NEK1 DST ANLN KMT2A DLD AFDN RABGEF1 KIF2A PPIP5K2 RASAL2 NEDD4L POTEF SIK3 CCNF MST1R YAF2 SH3PXD2A CGNL1 MTREX PARD3 CDC25B AHNAK2 | 4.53e-05 | 1014 | 245 | 28 | int:YWHAB |
| Interaction | UBE2S interactions | 4.92e-05 | 138 | 245 | 9 | int:UBE2S | |
| Interaction | MPDZ interactions | 4.92e-05 | 107 | 245 | 8 | int:MPDZ | |
| Interaction | E2F3 interactions | 4.96e-05 | 79 | 245 | 7 | int:E2F3 | |
| Interaction | MDC1 interactions | SRP68 SSR1 FZR1 BRCA1 BRCA2 ANLN MGA TCF20 LYAR CREBBP KIF20A SETD2 NKX2-1 TPX2 PAXIP1 SLX4 | 5.08e-05 | 414 | 245 | 16 | int:MDC1 |
| Interaction | SIPA1L1 interactions | SIPA1L3 SYNPO GAB2 ANLN AFDN RASAL2 LATS2 SH3PXD2A PARD3 CDC25B | 5.54e-05 | 174 | 245 | 10 | int:SIPA1L1 |
| Interaction | HDAC2 interactions | KLF8 ZMYM2 IRS1 FZR1 BRCA1 BRCA2 G3BP2 KMT2A UTP20 CDYL ZEB1 TCF20 CREBBP POLR3A CCNA2 KIF20A CCNF YAF2 LATS2 ZNF827 ZNF516 PRDX1 TPX2 CNTNAP2 AHNAK2 | 5.76e-05 | 865 | 245 | 25 | int:HDAC2 |
| Interaction | HSPA4L interactions | KLF8 RC3H1 FZR1 BRCA1 ANLN KIF2A RANBP3 RNF213 KIF20A CCNF LATS2 PAXIP1 | 5.93e-05 | 250 | 245 | 12 | int:HSPA4L |
| Interaction | CDH18 interactions | 5.99e-05 | 7 | 245 | 3 | int:CDH18 | |
| Interaction | WWTR1 interactions | SYNRG LIN7C SRP68 NEK1 ANLN KMT2A AFDN TTF2 ZEB1 TCF20 CREBBP SETD2 LATS2 NKX2-1 QSER1 PARD3 | 6.36e-05 | 422 | 245 | 16 | int:WWTR1 |
| Interaction | YWHAZ interactions | SYNRG CEP85L SIPA1L3 SYNPO IRS1 GAB2 CRACD NEK1 FZR1 DST BRCA1 ANLN KMT2A DLD AFDN RABGEF1 KIF2A PPIP5K2 RASAL2 FNDC3B DMXL2 NEDD4L POTEF SIK3 CCNF MST1R YAF2 LATS2 SH3PXD2A CGNL1 MTREX PARD3 CDC25B | 6.41e-05 | 1319 | 245 | 33 | int:YWHAZ |
| Interaction | POTEKP interactions | 7.24e-05 | 58 | 245 | 6 | int:POTEKP | |
| Interaction | EIF3I interactions | KLF8 RC3H1 SRP68 FZR1 BRCA1 ANLN G3BP2 DLD LYAR CCNF SETD2 PAXIP1 | 8.01e-05 | 258 | 245 | 12 | int:EIF3I |
| Interaction | MAGI1 interactions | 8.04e-05 | 147 | 245 | 9 | int:MAGI1 | |
| Interaction | GOLGA2 interactions | FAM161B GPKOW ANLN SPATA22 C2CD6 STX7 TCF20 SCAF8 POLDIP3 RANBP3 UBR4 RNF213 CCDC187 FNDC3A ZC2HC1C FAM90A1 STRIP1 USP2 TPX2 PAXIP1 FOXP1 UTP14C | 9.50e-05 | 733 | 245 | 22 | int:GOLGA2 |
| Interaction | YWHAQ interactions | SYNRG CEP85L RC3H1 SIPA1L3 IRS1 GAB2 NEK1 DST BRCA1 ANLN KMT2A DLD AFDN RABGEF1 PPIP5K2 DYNC1I2 RASAL2 NEDD4L POTEF SIK3 CCNF MST1R YAF2 SH3PXD2A PRDX1 CGNL1 MTREX PARD3 CDC25B | 9.94e-05 | 1118 | 245 | 29 | int:YWHAQ |
| Interaction | TOP3B interactions | SYNRG SIPA1L3 IRS1 ITGA5 LARP4 STK11IP NSD3 FZR1 BMP8B DST PIK3CD G3BP2 DOCK6 CRAMP1 COL1A1 BAHCC1 UNC13B FRAS1 POLDIP3 UBR4 LYAR PIKFYVE CCNF MST1R C2CD3 ERLIN2 LATS2 MAP1S ZNF827 SLC25A39 ZNF516 GKAP1 PAXIP1 GGA1 AHNAK2 | 1.01e-04 | 1470 | 245 | 35 | int:TOP3B |
| Interaction | CGN interactions | 1.04e-04 | 152 | 245 | 9 | int:CGN | |
| Interaction | CCNA1 interactions | 1.16e-04 | 63 | 245 | 6 | int:CCNA1 | |
| Interaction | H3C3 interactions | MIS18BP1 ZMYM2 PHF8 GPKOW NSD3 BRCA1 ANLN TONSL KMT2A CDYL MGA TCF20 LYAR KIF20A NKX2-1 TPX2 QSER1 | 1.26e-04 | 495 | 245 | 17 | int:H3C3 |
| Interaction | HSPH1 interactions | KLF8 RC3H1 FZR1 BRCA1 ANLN G3BP2 DLD DYNC1I2 ANKRD35 FNDC3B ZEB1 RANBP3 FNDC3A CCNF SLX4 XPO7 | 1.27e-04 | 448 | 245 | 16 | int:HSPH1 |
| Interaction | NECTIN1 interactions | 1.31e-04 | 22 | 245 | 4 | int:NECTIN1 | |
| Interaction | NIN interactions | CEP85L SIPA1L3 TUBGCP2 BRCA2 ANLN AFDN CPLANE1 MGA DYNC1I2 TTF2 CCDC22 C2CD3 LATS2 CGNL1 | 1.36e-04 | 359 | 245 | 14 | int:NIN |
| Interaction | RASAL2 interactions | 1.40e-04 | 158 | 245 | 9 | int:RASAL2 | |
| Interaction | DYRK1A interactions | SIPA1L3 SRPK1 IRS1 FZR1 BRCA1 ANLN TONSL DOCK6 LYAR CREBBP CCNA2 KIF20A LATS2 TPX2 KNDC1 SLX4 AHNAK2 XPO7 | 1.52e-04 | 552 | 245 | 18 | int:DYRK1A |
| Interaction | HNRNPCL3 interactions | 1.57e-04 | 23 | 245 | 4 | int:HNRNPCL3 | |
| Interaction | FAM110B interactions | 1.63e-04 | 67 | 245 | 6 | int:FAM110B | |
| Interaction | PAX6 interactions | ZMYM2 LARP4 GMPS C2CD6 MGA ZEB1 RANBP3 RFXAP CREBBP YAF2 ZNF516 PAXIP1 FOXP1 QSER1 | 1.67e-04 | 366 | 245 | 14 | int:PAX6 |
| Interaction | CXADR interactions | SIPA1L3 SSTR3 POTEE DST AFDN STX7 RASAL2 KIAA1549 FNDC3A LATS2 SPRY4 CNTNAP2 EFR3B PARD3 | 1.81e-04 | 369 | 245 | 14 | int:CXADR |
| Interaction | TESK2 interactions | 1.83e-04 | 97 | 245 | 7 | int:TESK2 | |
| Interaction | SRSF12 interactions | 1.93e-04 | 130 | 245 | 8 | int:SRSF12 | |
| Interaction | DOC2B interactions | 2.00e-04 | 10 | 245 | 3 | int:DOC2B | |
| Interaction | HDAC1 interactions | ZMYM2 MCM4 SSR1 XYLT2 NEK1 FZR1 DST BRCA1 BRCA2 ANLN KMT2A CDYL KIF2A MGA BAHCC1 CASP8AP2 ZEB1 TCF20 UBR4 CREBBP POLR3A KIF20A CCNF YAF2 LATS2 ZNF827 NKX2-1 ZNF516 | 2.03e-04 | 1108 | 245 | 28 | int:HDAC1 |
| Interaction | CGAS interactions | MIS18BP1 SRP68 CHD2 TUBGCP2 PHF8 LARP4 BRCA1 ANLN CDYL KIF2A LYAR KIF20A NKX2-1 | 2.08e-04 | 329 | 245 | 13 | int:CGAS |
| Interaction | TIAM1 interactions | ABCA1 LIN7C RYR3 STX7 RASAL2 FNDC3B CREBBP SH3PXD2A PARD3 CDC25B | 2.14e-04 | 205 | 245 | 10 | int:TIAM1 |
| Interaction | NUP43 interactions | MIS18BP1 ZMYM2 PHF8 NSD3 TASOR2 DST BRCA1 BRCA2 TONSL KMT2A UTP20 KIF2A MGA CASP8AP2 TCF20 SETD2 NKX2-1 SLX4 AHNAK2 | 2.45e-04 | 625 | 245 | 19 | int:NUP43 |
| Interaction | CDC27 interactions | SRP68 PHF8 FZR1 BRCA1 KMT2A CREBBP CCNA2 CCNF ELMO2 TPX2 PAXIP1 | 2.48e-04 | 249 | 245 | 11 | int:CDC27 |
| Interaction | NVL interactions | 2.53e-04 | 171 | 245 | 9 | int:NVL | |
| Interaction | H2BC8 interactions | MIS18BP1 ZMYM2 GPKOW NSD3 POTEE BRCA1 ANLN KMT2A DLD CDYL MGA ZEB1 TCF20 LYAR CCNA2 KIF20A TPX2 QSER1 | 2.56e-04 | 576 | 245 | 18 | int:H2BC8 |
| Interaction | MARK1 interactions | 2.82e-04 | 74 | 245 | 6 | int:MARK1 | |
| Interaction | RPRD1A interactions | 2.87e-04 | 174 | 245 | 9 | int:RPRD1A | |
| Interaction | HSP90AB1 interactions | SPEF2 CHD2 TUBGCP2 SSR4 FZR1 BRCA1 BRCA2 ANLN KMT2A RABGEF1 DYNC1I2 UNC13B TTF2 DMXL2 UBR4 FNDC3A SIK3 CREBBP KIF20A CCNF YAF2 AGO1 LATS2 CGNL1 SLX4 | 2.90e-04 | 960 | 245 | 25 | int:HSP90AB1 |
| Interaction | CPNE8 interactions | 2.98e-04 | 105 | 245 | 7 | int:CPNE8 | |
| Interaction | DRG1 interactions | SRPK1 SSR1 SSR4 LARP4 FZR1 BRCA1 ANLN G3BP2 LYAR CCNF SH3GLB1 ELMO2 PAXIP1 MTREX | 3.03e-04 | 388 | 245 | 14 | int:DRG1 |
| Interaction | PARD3 interactions | SIPA1L3 EPB41L4A DST AFDN STX7 RASAL2 KIAA1549 KIF20A CCNF LATS2 EFR3B PARD3 | 3.06e-04 | 298 | 245 | 12 | int:PARD3 |
| Interaction | ITPR1 interactions | 3.36e-04 | 141 | 245 | 8 | int:ITPR1 | |
| Interaction | POLR1G interactions | RC3H1 TRPC4 CHD2 PHF8 NSD3 KMT2A DLD UTP20 MGA TCF20 UBR4 LYAR POLR3A KIF20A ZNF516 XPO7 | 3.41e-04 | 489 | 245 | 16 | int:POLR1G |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 4.48e-08 | 13 | 150 | 5 | 685 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 1.99e-05 | 20 | 150 | 4 | 548 | |
| GeneFamily | Ankyrin repeat domain containing | 9.45e-04 | 242 | 150 | 8 | 403 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 9.97e-04 | 24 | 150 | 3 | 485 | |
| GeneFamily | PDZ domain containing | 1.69e-03 | 152 | 150 | 6 | 1220 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 2.77e-03 | 34 | 150 | 3 | 487 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.27e-03 | 36 | 150 | 3 | 823 | |
| GeneFamily | Bone morphogenetic proteins|Astacins | 3.58e-03 | 11 | 150 | 2 | 455 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 3.58e-03 | 11 | 150 | 2 | 1168 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ZMYM2 IRS1 PHF8 LARP4 GMPS NEK1 DLC1 DST BRCA1 BRCA2 UTP20 CDYL KIF2A PPIP5K2 DMXL2 ZEB1 SCAF8 FNDC3A SIK3 CREBBP TGFB2 PIKFYVE SETD2 C2CD3 YAF2 RBM6 MTREX PARD3 | 1.56e-08 | 856 | 250 | 28 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | ZMYM2 IRS1 LARP4 GMPS DLC1 DST BRCA1 CDYL KIF2A SCAF8 FNDC3A CREBBP TGFB2 PIKFYVE SETD2 C2CD3 RBM6 MTREX PARD3 | 1.33e-07 | 466 | 250 | 19 | M13522 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_EARLY_STALK_CELL | PRTG MCM4 SLC12A5 BRCA1 BRCA2 ANLN PLCL2 TONSL HRH2 PARPBP TTF2 PCLO CCNA2 KIF20A CCNF TPX2 CNTNAP2 CDC25B CDH6 | 2.51e-06 | 567 | 250 | 19 | M45692 |
| Coexpression | WHITFIELD_CELL_CYCLE_LITERATURE | 3.69e-06 | 44 | 250 | 6 | M2066 | |
| Coexpression | GSE14699_NAIVE_VS_ACT_CD8_TCELL_DN | ABCA1 ZMYM2 TASOR2 EML5 MGA ZEB1 NEDD4L SH3PXD2A FOXP1 QSER1 | 7.51e-06 | 175 | 250 | 10 | M2940 |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP | CXCL10 MCM4 ANLN GORAB PARPBP COL1A1 TTF2 CCNA2 CCNF SLC44A1 GZMH GZMB QSER1 | 8.27e-06 | 305 | 250 | 13 | M19875 |
| Coexpression | GSE3920_UNTREATED_VS_IFNG_TREATED_FIBROBLAST_DN | SPEF2 ZMYM2 ITGA5 XYLT2 DST EML5 ARHGAP31 RIPK3 NEDD4L ATP10D | 9.16e-06 | 179 | 250 | 10 | M6689 |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP | MIS18BP1 CXCL10 BRCA1 BRCA2 PPIP5K2 CD200R1L RIPK3 RNF213 CCNA2 TPX2 | 1.11e-05 | 183 | 250 | 10 | M2993 |
| Coexpression | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1 | MIS18BP1 MCM4 IRS1 BMP8B DLC1 DST NECAB1 GOLIM4 KIF20A STC2 ZNF516 TPX2 QSER1 CDC25B ENPEP AHNAK2 UTP14C | 1.66e-05 | 534 | 250 | 17 | M12522 |
| Coexpression | GSE7831_CPG_VS_INFLUENZA_STIM_PDC_1H_UP | 2.40e-05 | 200 | 250 | 10 | M6950 | |
| Coexpression | BROWNE_HCMV_INFECTION_14HR_DN | IRS1 NEK1 DST PIK3CD DYNC1I2 TTF2 CCDC22 ERLIN2 STC2 CDC25B CDH6 AHNAK2 | 2.47e-05 | 290 | 250 | 12 | M13251 |
| Coexpression | GSE14415_FOXP3_KO_NATURAL_TREG_VS_TCONV_UP | 4.12e-05 | 171 | 250 | 9 | M2947 | |
| Coexpression | HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP | 4.73e-05 | 68 | 250 | 6 | M41108 | |
| Coexpression | SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN | 5.16e-05 | 22 | 250 | 4 | M9402 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_FZD8CRD_UP | MIS18BP1 BCL2L12 BRCA1 BRCA2 ARHGAP31 ANLN TONSL KIF2A PARPBP FANCM CCNA2 KIF20A CCNF CRACDL TPX2 EFR3B CDC25B | 5.54e-05 | 588 | 250 | 17 | M38992 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 6.13e-05 | 180 | 250 | 9 | M8239 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_PRO_B_CELL | MCM4 ITGA5 GAB2 GMPS BCL2L12 BRCA1 BRCA2 ANLN PARPBP TTF2 CCNA2 KIF20A CCNF SLC44A1 TPX2 | 6.15e-05 | 478 | 250 | 15 | M45785 |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM | 7.26e-05 | 228 | 250 | 10 | MM1014 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | CXCL10 MCM4 NSD3 GMPS BRCA1 BRCA2 ANLN GORAB PARPBP COL1A1 CASP8AP2 TTF2 FNDC3B FRAS1 DEPP1 RNF213 LYAR FANCM CCNA2 KIF20A CCNF SLC44A1 YAF2 GZMH GZMB TPX2 CNTNAP2 PAXIP1 QSER1 | 8.27e-05 | 1407 | 250 | 29 | M14427 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_SCHWANN_PRECURSOR_CELL | MIS18BP1 MCM4 BCL2L12 ANLN PARPBP LYAR CCNA2 KIF20A TGFB2 TPX2 | 8.38e-05 | 232 | 250 | 10 | M45800 |
| Coexpression | GAVIN_PDE3B_TARGETS | 8.73e-05 | 25 | 250 | 4 | MM726 | |
| Coexpression | FISCHER_G2_M_CELL_CYCLE | 9.65e-05 | 236 | 250 | 10 | M130 | |
| Coexpression | MARKEY_RB1_ACUTE_LOF_UP | MIS18BP1 MCM4 BRCA1 BRCA2 ANLN KIF2A CASP8AP2 CCNA2 KIF20A CCNF | 1.00e-04 | 237 | 250 | 10 | M15606 |
| Coexpression | ZHONG_PFC_C1_OPC | MIS18BP1 BRCA1 ANLN PARPBP CCNA2 KIF20A CCNF TPX2 QSER1 CDC25B | 1.03e-04 | 238 | 250 | 10 | M39096 |
| Coexpression | GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_30MIN_DN | 1.05e-04 | 193 | 250 | 9 | M6903 | |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_UP | 1.09e-04 | 194 | 250 | 9 | M7467 | |
| Coexpression | MARKEY_RB1_ACUTE_LOF_UP | MIS18BP1 MCM4 BRCA1 BRCA2 ANLN KIF2A CASP8AP2 CCNA2 KIF20A CCNF | 1.11e-04 | 240 | 250 | 10 | MM976 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_PROMONOCYTE_LIKE_CELL | MCM4 BCL2L12 BRCA1 BRCA2 ANLN CCNA2 KIF20A CCNF SLC44A1 TPX2 CDC25B | 1.17e-04 | 290 | 250 | 11 | M45736 |
| Coexpression | GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_DN | MIS18BP1 EPB41L4A NSD3 CRACD KIF2A CRAMP1 RANBP3 DEPP1 FOXP1 | 1.27e-04 | 198 | 250 | 9 | M3352 |
| Coexpression | GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP | 1.37e-04 | 200 | 250 | 9 | M3580 | |
| Coexpression | GSE17721_CTRL_VS_PAM3CSK4_12H_BMDC_UP | 1.37e-04 | 200 | 250 | 9 | M3749 | |
| Coexpression | GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP | 1.37e-04 | 200 | 250 | 9 | M8500 | |
| Coexpression | GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_MEMORY_CD8_TCELL_UP | 1.37e-04 | 200 | 250 | 9 | M3663 | |
| Coexpression | WU_APOPTOSIS_BY_CDKN1A_VIA_TP53 | 1.50e-04 | 53 | 250 | 5 | M10169 | |
| Coexpression | GSE25677_MPL_VS_MPL_AND_R848_STIM_BCELL_UP | 1.57e-04 | 160 | 250 | 8 | M8183 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_12H_DN | 1.71e-04 | 162 | 250 | 8 | M7002 | |
| Coexpression | BENPORATH_CYCLING_GENES | MIS18BP1 MCM4 FZR1 BRCA1 ANLN PIK3CD AFDN CPLANE1 CASP8AP2 TTF2 DMXL2 LYAR CCNA2 CCNF TTC31 TPX2 CDC25B | 1.78e-04 | 648 | 250 | 17 | M8156 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_UP | 1.78e-04 | 163 | 250 | 8 | M8235 | |
| Coexpression | FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP | 1.86e-04 | 164 | 250 | 8 | M19957 | |
| Coexpression | KIM_WT1_TARGETS_DN | MIS18BP1 IRS1 LARP4 DLC1 C7orf25 COL1A1 TTF2 LIAS ATP10D CCNA2 KIF20A TGFB2 PIKFYVE CCNF | 1.90e-04 | 471 | 250 | 14 | M17859 |
| Coexpression | GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_UP | 2.02e-04 | 166 | 250 | 8 | M7009 | |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | SRPK1 MCM4 GMPS BRCA1 BRCA2 TTF2 RFXAP CCNA2 PIKFYVE CCNF TPX2 PAXIP1 CDC25B | 2.49e-04 | 426 | 250 | 13 | M9516 |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM | 2.52e-04 | 217 | 250 | 9 | M16407 | |
| Coexpression | FARMER_BREAST_CANCER_CLUSTER_2 | 2.66e-04 | 33 | 250 | 4 | M17333 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | MIS18BP1 SRPK1 MCM4 LARP4 GMPS BCL2L12 FZR1 BRCA1 BRCA2 ANLN PLCL2 PARPBP CASP8AP2 TTF2 ZEB1 RANBP3 CCNA2 KIF20A CCNF SLC44A1 TPX2 | 2.84e-04 | 939 | 250 | 21 | M45768 |
| Coexpression | VILLANUEVA_LIVER_CANCER_KRT19_UP | 2.89e-04 | 175 | 250 | 8 | M336 | |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_CD4_TCELL_UP | 3.01e-04 | 176 | 250 | 8 | M8881 | |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP | 3.01e-04 | 176 | 250 | 8 | M2981 | |
| Coexpression | CROONQUIST_IL6_DEPRIVATION_DN | 3.03e-04 | 95 | 250 | 6 | M18506 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | MIS18BP1 MCM4 TUBGCP2 GMPS BRCA2 ANLN TONSL PPIP5K2 PARPBP SYT13 FANCM CCNA2 KIF20A PNMA8A TPX2 PAXIP1 CDC25B | 3.12e-04 | 680 | 250 | 17 | MM456 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | PRTG LIN7C SRRM4 ZMYM2 CHD2 EPB41L4A LARP4 CRACD NEK1 EML5 BRCA1 BRCA2 UTP20 KIF2A RASAL2 NOVA1 UNC13B CASP8AP2 NEDD4L PCLO LYAR SETD2 AGO1 SAMD10 NKX2-1 TPX2 GKAP1 CNTNAP2 CDC25B CDH7 | 1.15e-06 | 989 | 243 | 30 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | PRTG MIS18BP1 FSIP1 PHF8 EPB41L4A LARP4 TASOR2 NEK1 EML5 BRCA1 BRCA2 ANLN CPLANE1 PARPBP MGA RASAL2 NOVA1 UNC13B CASP8AP2 DMXL2 VPS50 PIKFYVE CARF GKAP1 TDRD12 | 8.78e-06 | 820 | 243 | 25 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_500 | 1.81e-05 | 129 | 243 | 9 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k4_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#1 | LIN7C SRRM4 RASAL2 UNC13B AGO1 SAMD10 NKX2-1 CNTNAP2 CDC25B CDH7 | 3.87e-05 | 177 | 243 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | CEP85L EPB41L4A LARP4 GMPS EML5 BRCA1 BRCA2 ANLN NOVA1 CASP8AP2 TTF2 PCLO LYAR FANCM TPX2 PAXIP1 RBM6 UTP14C | 4.48e-05 | 532 | 243 | 18 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | PRTG LIN7C SRRM4 EPB41L4A EML5 BRCA1 BRCA2 RASAL2 NOVA1 CASP8AP2 PCLO LYAR NKX2-1 TPX2 GKAP1 CNTNAP2 CDH7 | 6.55e-05 | 498 | 243 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | 7.86e-05 | 90 | 243 | 7 | GSM399397_100 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | MIS18BP1 MCM4 ITGAM BRCA1 BRCA2 ANLN PARPBP RIPK3 FANCM CCNA2 KIF20A CCNF GZMB TPX2 CDC25B | 8.24e-05 | 410 | 243 | 15 | GSM538387_500 |
| CoexpressionAtlas | facebase_RNAseq_e9.5_OlfPlac_2500_K3 | MIS18BP1 SIPA1L3 SRPK1 MCM4 IRS1 EPB41L4A POTEE CRACD BCL2L12 FZR1 EML5 BRCA2 PLCL2 KIAA1958 AFDN PARPBP RASAL2 BAHCC1 POLDIP3 LYAR FANCM ZNF496 CCNF YAF2 STC2 PRDX1 TPX2 CNTNAP2 PLXNA4 | 9.87e-05 | 1187 | 243 | 29 | facebase_RNAseq_e9.5_OlfPlac_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | MIS18BP1 CEP85L ZMYM2 MCM4 GMPS CRACD EML5 BRCA1 BRCA2 ANLN UTP20 KIF2A CPLANE1 PARPBP CASP8AP2 ZEB1 NEDD4L VPS50 KIAA1549 LYAR FANCM CCNA2 USP2 TPX2 CNTNAP2 PAXIP1 QSER1 PNPLA7 MTREX CDH6 | 1.13e-04 | 1257 | 243 | 30 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500 | PRTG MIS18BP1 PHF8 TASOR2 NEK1 EML5 BRCA1 BRCA2 ANLN CPLANE1 CASP8AP2 DMXL2 GKAP1 TDRD12 | 1.51e-04 | 385 | 243 | 14 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | PRTG LIN7C SRRM4 CHD2 SYNPO LARP4 EML5 BRCA1 BRCA2 NRK UTP20 RASAL2 NOVA1 CASP8AP2 NEDD4L PCLO LYAR FANCM AGO1 TPX2 GKAP1 CNTNAP2 KNDC1 CDC25B CDH7 | 1.66e-04 | 983 | 243 | 25 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | PRTG SRRM4 LARP4 EML5 BRCA1 BRCA2 UTP20 NOVA1 CASP8AP2 NEDD4L PCLO LYAR TPX2 GKAP1 CNTNAP2 CDH7 | 1.91e-04 | 493 | 243 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000 | MIS18BP1 MCM4 EPB41L4A GAB2 NSD3 GMPS BRCA1 ANLN KIF2A PARPBP NOVA1 ZEB1 FAM13C DOCK10 KIAA1549 TGFB3 LATS2 DCAF12L1 SPRY4 TPX2 CGNL1 CDH6 | 1.95e-04 | 819 | 243 | 22 | gudmap_developingKidney_e15.5_Peripheral blastema_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | MIS18BP1 LIN7C ZMYM2 SRPK1 CRACD EML5 BRCA1 BRCA2 KIAA1958 KIF2A CPLANE1 PARPBP DYNC1I2 RASAL2 UNC13B CASP8AP2 ZEB1 NEDD4L SIK3 FANCM USP2 AGO1 SAMD10 STC2 TPX2 GKAP1 CNTNAP2 EFR3B TCEANC2 CDC25B CDH6 | 2.22e-04 | 1370 | 243 | 31 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | ZMYM2 CHD2 EPB41L4A GPKOW CRACD NEK1 EML5 BRCA1 BRCA2 GOLIM4 KIF2A NOVA1 CASP8AP2 DMXL2 TCF20 NEDD4L PCLO LYAR SETD2 TPX2 GKAP1 SLX4 | 2.39e-04 | 831 | 243 | 22 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | MIS18BP1 CEP85L ZMYM2 NSD3 SLC12A5 GMPS CRACD TTC7B BRCA2 PLCL2 CDYL KIF2A PPIP5K2 CPLANE1 PARPBP DYNC1I2 CASP8AP2 ZEB1 NEDD4L VPS50 KIAA1549 LYAR FANCM CCNA2 TPX2 TCEANC2 QSER1 MTREX CDH6 | 2.44e-04 | 1252 | 243 | 29 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | SYNRG ABCA1 LIN7C SRRM4 DST EML5 BRCA1 RASAL2 NOVA1 UNC13B CASP8AP2 NEDD4L PCLO TMEM151B RSPH3 C2CD3 AGO1 NKX2-1 TPX2 GKAP1 CNTNAP2 CDC25B CDH7 | 2.56e-04 | 893 | 243 | 23 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.76e-04 | 110 | 243 | 7 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k4_1000 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA1 GJD2 IRS1 F8 DST EML5 NECAB1 GOLIM4 SYT13 FRAS1 PCLO SH3PXD2A CNTNAP2 PAXIP1 | 2.00e-12 | 178 | 252 | 14 | fcbbcc44271515de1969b4732b6441c012693d5f |
| ToppCell | 10x5'-Liver-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|Liver / Manually curated celltypes from each tissue | DZIP1L CRACD BCL2L12 BRCA2 ANLN HRH2 BAHCC1 FANCM CCNA2 KIF20A TPX2 | 3.00e-09 | 166 | 252 | 11 | a176e87aa6eec81d1fb79a028f759182d11b567d |
| ToppCell | 10x5'-Liver-Hematopoietic_progenitors|Liver / Manually curated celltypes from each tissue | DZIP1L CRACD BCL2L12 BRCA2 ANLN HRH2 BAHCC1 FANCM CCNA2 KIF20A TPX2 | 3.00e-09 | 166 | 252 | 11 | ae967570248cf86ca3ddf55e33bcbb3e4e3684bc |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA1 GJD2 SSTR3 DST USH2A SYT13 PCLO SH3PXD2A CNTNAP2 PAXIP1 PARD3 | 1.37e-08 | 192 | 252 | 11 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | SIPA1L3 EPB41L4A KIAA1958 AFDN FRAS1 NEDD4L ZNF827 CGNL1 PARD3 CDH6 ENPEP | 1.53e-08 | 194 | 252 | 11 | 7002937e8903e037332a215d00fbc7c7843b33f2 |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MIS18BP1 MCM4 CRACD BRCA1 ANLN DMXL2 RPH3A CCNA2 KIF20A CCNF TPX2 | 1.53e-08 | 194 | 252 | 11 | effd38e51062b225ecabc7e1c50154e65495d559 |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / Treatment groups by lineage, cell group, cell type | MIS18BP1 LIN7C RC3H1 BRCA2 ANLN PARPBP CCNA2 KIF20A CCNF AGO1 TPX2 | 1.79e-08 | 197 | 252 | 11 | 038fd92750257d43d5e980fd06d77742b543f11a |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | MIS18BP1 MCM4 BRCA1 BRCA2 ANLN PARPBP TTF2 CCNA2 KIF20A CCNF TPX2 | 2.09e-08 | 200 | 252 | 11 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | GJD2 IRS1 F8 NECAB1 FRAS1 PCLO KIAA1549 SH3PXD2A CNTNAP2 PAXIP1 | 6.13e-08 | 174 | 252 | 10 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.00e-08 | 179 | 252 | 10 | ce3ca7f3a5864e62307aa744a3173f350a90df28 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | MIS18BP1 BRCA1 BRCA2 ANLN PARPBP TTF2 CCNA2 KIF20A CCNF TPX2 | 8.43e-08 | 180 | 252 | 10 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f |
| ToppCell | P15-Endothelial-proliferative_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | MIS18BP1 FZR1 BRCA1 ANLN PARPBP CCNA2 KIF20A CCNF TPX2 CDC25B | 8.88e-08 | 181 | 252 | 10 | 0c5bc1660b8fc1e905ab4230202862de5be46ebd |
| ToppCell | P15-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | MIS18BP1 FZR1 BRCA1 ANLN PARPBP CCNA2 KIF20A CCNF TPX2 CDC25B | 8.88e-08 | 181 | 252 | 10 | f83565f09dd971c5cad2704a4a86bca0accd955e |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MIS18BP1 SPEF2 ANLN PLCL2 PARPBP TTF2 CCNA2 KIF20A CCNF TPX2 | 9.35e-08 | 182 | 252 | 10 | 0fc45214f0b0766f69be6eff69cc4bec574023aa |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MIS18BP1 ANLN PARPBP PCDHGB2 ZNF496 CCNA2 KIF20A CCNF TPX2 CDC25B | 1.15e-07 | 186 | 252 | 10 | 3993f1ef8a33b8a75dfd3db8d4845b5afbb0bb3d |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MIS18BP1 ANLN PARPBP PCDHGB2 ZNF496 CCNA2 KIF20A CCNF TPX2 CDC25B | 1.15e-07 | 186 | 252 | 10 | ec6d0c29e196e374baa96dd3d506f489c959e77e |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | MIS18BP1 BRCA1 BRCA2 ANLN PARPBP TTF2 CCNA2 KIF20A CCNF TPX2 | 1.33e-07 | 189 | 252 | 10 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | GJD2 SSTR3 DST SYT13 PCLO DCAF12L1 SH3PXD2A ZNF516 CNTNAP2 PAXIP1 | 1.78e-07 | 195 | 252 | 10 | bd8e24dd598990204998d1dd853ba7a53dc0107e |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.78e-07 | 195 | 252 | 10 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-T_NK_proliferative|ICU-SEP / Disease, Lineage and Cell Type | 1.96e-07 | 197 | 252 | 10 | 908e91fa16134b61943aea5e8fc0d6fbac8a8c6e | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic-granulocyte|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | MIS18BP1 MCM4 BRCA1 BRCA2 ANLN BAHCC1 CCNA2 KIF20A SLC44A1 TPX2 | 2.05e-07 | 198 | 252 | 10 | 2e669da80363163b806f23a645474d482797ae5d |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.05e-07 | 198 | 252 | 10 | 80b105a7c7d00ea3b5e586831fbb755bd84f9d1a | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-1|bone_marrow / Manually curated celltypes from each tissue | 2.05e-07 | 198 | 252 | 10 | 5c92687b853ebb00960adbef6552f9d460bc6886 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Proliferating-cycling_dorsal_progenitors|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | MIS18BP1 BRCA1 BRCA2 ANLN PARPBP CCNA2 KIF20A CCNF TPX2 CDC25B | 2.05e-07 | 198 | 252 | 10 | dada1c19a261c8e1090957cd7e37f2a43a9fe14f |
| ToppCell | T_cells-GZMK+GZMB+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.05e-07 | 198 | 252 | 10 | 085ba270f9defbf5ef45108c6d870e1d7c428479 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating-cycling_dorsal_progenitors|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | MIS18BP1 BCL2L12 FZR1 ANLN PARPBP CCNA2 KIF20A CCNF TPX2 CDC25B | 2.05e-07 | 198 | 252 | 10 | 5f0964c3aa7e1dc52cbb46e754078920b65bcb88 |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.05e-07 | 198 | 252 | 10 | c73e906d2d12d6eba0e606958be16e63a2292cd0 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.15e-07 | 199 | 252 | 10 | 305a9ade5bbe8e981e7c641c9a5e0c9f8ef60470 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating-Cycling_Progenitors|6_mon / Sample Type, Dataset, Time_group, and Cell type. | MIS18BP1 MCM4 BRCA1 BRCA2 ANLN PARPBP CCNA2 KIF20A TPX2 CDC25B | 2.15e-07 | 199 | 252 | 10 | a99516a5760f49a69b0fe45a9b2316e393252966 |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div1|World / Primary Cells by Cluster | MIS18BP1 BRCA2 ANLN PARPBP ZEB1 CCNA2 KIF20A CCNF TPX2 CDC25B | 2.15e-07 | 199 | 252 | 10 | 72823f26ecabcae1b514b7629cfce010c97b929a |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div1-28|World / Primary Cells by Cluster | MIS18BP1 BRCA2 ANLN PARPBP ZEB1 CCNA2 KIF20A CCNF TPX2 CDC25B | 2.15e-07 | 199 | 252 | 10 | 787688b68ae5d8768c0a24673ae07ab07616764a |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | MIS18BP1 BRCA1 BRCA2 ANLN PARPBP TTF2 CCNA2 KIF20A CCNF TPX2 | 2.15e-07 | 199 | 252 | 10 | be2276c9a1994579ba1d2998b49bf549c1324d44 |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | MIS18BP1 BRCA1 BRCA2 ANLN PARPBP TTF2 CCNA2 KIF20A CCNF TPX2 | 2.25e-07 | 200 | 252 | 10 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NKT-proliferating|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.25e-07 | 200 | 252 | 10 | 87e293c0882e2754756a2210a6c04723dc89f81b | |
| ToppCell | Sepsis-ICU-SEP-Lymphocyte-T/NK-T/NK_proliferative|ICU-SEP / Disease, condition lineage and cell class | 2.25e-07 | 200 | 252 | 10 | ae500c8b7c2162cadd31bf44ee9dc3271192cf17 | |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD8_T_cells|Lymphoid / Condition, Lineage and Cell class | 2.25e-07 | 200 | 252 | 10 | 4556bb626ca1a00a6db13d2adb35acb8ba848f9c | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells-Neuroepithelial_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | MIS18BP1 MCM4 BRCA1 BRCA2 ANLN PARPBP CCNA2 KIF20A TPX2 CDC25B | 2.25e-07 | 200 | 252 | 10 | 8f8b8c225cdc79baf16fe04be89bdb65e404a055 |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells|10w / Sample Type, Dataset, Time_group, and Cell type. | MIS18BP1 MCM4 BRCA1 BRCA2 ANLN PARPBP CCNA2 KIF20A TPX2 CDC25B | 2.25e-07 | 200 | 252 | 10 | a1f48eca9efb4f3ec3c9ace20f8c9257dd72c4ed |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.25e-07 | 200 | 252 | 10 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Stem_cells-Neuroepithelial_cell|GW26 / Sample Type, Dataset, Time_group, and Cell type. | MIS18BP1 BCL2L12 BRCA1 BRCA2 ANLN PARPBP CCNA2 KIF20A TPX2 CDC25B | 2.25e-07 | 200 | 252 | 10 | 203b9a5de4430713da01b3331e69381db449a3a0 |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Stem_cells|GW26 / Sample Type, Dataset, Time_group, and Cell type. | MIS18BP1 BCL2L12 BRCA1 BRCA2 ANLN PARPBP CCNA2 KIF20A TPX2 CDC25B | 2.25e-07 | 200 | 252 | 10 | a854e19703dc920e48304541e2b06ed013292f3e |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD8_T_cells|COVID-19 / Condition, Lineage and Cell class | 2.25e-07 | 200 | 252 | 10 | b239c711cce967826432fdbd5f88eba98a88bb0c | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating|6_mon / Sample Type, Dataset, Time_group, and Cell type. | MIS18BP1 MCM4 BRCA1 BRCA2 ANLN PARPBP CCNA2 KIF20A TPX2 CDC25B | 2.25e-07 | 200 | 252 | 10 | 8f9e76048ae6f45218a09a95a2c4b31e8a8937b2 |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.97e-07 | 163 | 252 | 9 | 3efbbdc9cb2613bb76d8c2f07cd4ec1a2c51a622 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.97e-07 | 163 | 252 | 9 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.39e-07 | 169 | 252 | 9 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.39e-07 | 169 | 252 | 9 | 563c267edaade0e5df192ad953801ef9768d4270 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.88e-07 | 174 | 252 | 9 | c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.88e-07 | 174 | 252 | 9 | 72df66319f6efbd88ecf439013d97409fbf3cb52 | |
| ToppCell | droplet-Lung-18m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.57e-07 | 176 | 252 | 9 | b17317ac41d3215db55a38cbd3366c0947f7a2a3 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.94e-07 | 177 | 252 | 9 | 3e149bff1f1b393a7abe98984e37981c8296f95d | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.72e-07 | 179 | 252 | 9 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.72e-07 | 179 | 252 | 9 | 021d782134126c6f7dce6b6ea50cc54bdaa39987 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-secretory_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.56e-07 | 181 | 252 | 9 | b203b616584cdbd0bbb0e382b2916d0bd49d3526 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-1|bone_marrow / Manually curated celltypes from each tissue | 9.56e-07 | 181 | 252 | 9 | ccd0ed30cea3fb41d34f28b3e8d80a94493bef3c | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.56e-07 | 181 | 252 | 9 | e482fd116c00ff4d8db7be3c06b1bd1ffa2d479d | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.56e-07 | 181 | 252 | 9 | 2be3d44619adb25d339e7a27b500a56e07e8de01 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.56e-07 | 181 | 252 | 9 | c748c16fd20d1949d33ff6290dc9d9016c4dc86c | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.00e-06 | 182 | 252 | 9 | 21dcab170ffeef89faa9fee5008568cb6e15c694 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-06 | 182 | 252 | 9 | bc6a120dedc813c58baac1428c39851a07b71ba7 | |
| ToppCell | IIF-Lymphocyte-T_NK-T_NK_proliferative|IIF / Disease, Lineage and Cell Type | 1.10e-06 | 184 | 252 | 9 | ab8b45ce40e8c5f66e5c23332a591b4f9cba4ce1 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-06 | 184 | 252 | 9 | 16aa8e88bdd51b1d132d5cf33c29963b384a8bae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-06 | 185 | 252 | 9 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | CPAMD8 GJD2 IRS1 CNTNAP5 NEDD4L FAM13C DOCK10 SLC25A39 FOXP1 | 1.15e-06 | 185 | 252 | 9 | 9438097e94219c1db922b8507e3a29106d32a923 |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-06 | 186 | 252 | 9 | 9feef5936985e936b3d88f9d1bb012abb6468570 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-06 | 186 | 252 | 9 | 89f5b06bc56674af304912d481ac697c7c870904 | |
| ToppCell | moderate-Epithelial-Ionocyte|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.25e-06 | 187 | 252 | 9 | 3e3fe2d5712a0ac477cddefe56705d4b8d8f7eac | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-06 | 187 | 252 | 9 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4/8-lo-Cycling_T|blood / Manually curated celltypes from each tissue | 1.31e-06 | 188 | 252 | 9 | 714ccbcf826f26d39757931a3b8abbd952f4cddc | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-06 | 188 | 252 | 9 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 1.37e-06 | 189 | 252 | 9 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | Dividing_Macrophages-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.37e-06 | 189 | 252 | 9 | d4e88a3e50499d683e3db38aee04490146fe30bb | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-06 | 190 | 252 | 9 | b69940d16685249167d4c2cf6ad8237ccf6f7590 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.43e-06 | 190 | 252 | 9 | cd37ccd30c27cf65eda0a9165f35b7672f5acaf6 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.49e-06 | 191 | 252 | 9 | 0ba5b112a82e489f5a21966f78a403a7436ce73b | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.49e-06 | 191 | 252 | 9 | a7b18bcf27c38ad2353c239ecb309c80f3ef3359 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.56e-06 | 192 | 252 | 9 | 27723f4e320e49d4a3daafa2d8d3946ff79fab64 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.56e-06 | 192 | 252 | 9 | 026f3e38970bea1e6e8d76a4e2becdfb8484b2ff | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-06 | 192 | 252 | 9 | e8d47504b744040a762ec9b670a66cc060b2ae86 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.56e-06 | 192 | 252 | 9 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | Proliferating|World / shred by cell class for mouse tongue | 1.56e-06 | 192 | 252 | 9 | f081f3f957cc782294e118fcc1055f6a4264ee98 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.63e-06 | 193 | 252 | 9 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Control / Condition, Lineage and Cell class | 1.63e-06 | 193 | 252 | 9 | 33d409d6ed1c606337248587ad997ac5f67f081d | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.70e-06 | 194 | 252 | 9 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.70e-06 | 194 | 252 | 9 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.70e-06 | 194 | 252 | 9 | 5a519538327029ad2b880ef9647e2ac6ab3961a4 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.70e-06 | 194 | 252 | 9 | a12b64945e10f00aa983678a02586c59badc1570 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.70e-06 | 194 | 252 | 9 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-B_cells-Cycling_plasma_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.70e-06 | 194 | 252 | 9 | 06b8dc2e46f833707d5b68b324b4ff6c4d0dccf9 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|kidney / Disease (COVID-19 only), tissue and cell type | 1.77e-06 | 195 | 252 | 9 | 7e05e56f8d0a7a052830c7db12b10dace7d10760 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.77e-06 | 195 | 252 | 9 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.77e-06 | 195 | 252 | 9 | 742c82c86487314cdb3178012004adb1164bcbdb | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.77e-06 | 195 | 252 | 9 | c1435e61e4f0cf457f26ae436936048932ceb0db | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 195 | 252 | 9 | 93c345e70d6c8ff5d12fd63d73228c1700b804a0 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.85e-06 | 196 | 252 | 9 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.85e-06 | 196 | 252 | 9 | 9591a6a3477ed6a1e2e016f7542e38603d8b16cb | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.85e-06 | 196 | 252 | 9 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | ILEUM-non-inflamed-(1)_Highly_activated_T_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.85e-06 | 196 | 252 | 9 | 6a415a2574bd84bd825a2bd6c8e3632a433ff7cf | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.85e-06 | 196 | 252 | 9 | 5905f0e3061a6b98b7a33d64c782c3dda2cd51ef | |
| ToppCell | mild-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.85e-06 | 196 | 252 | 9 | b1d9866d5dfaefdb8bedaf01a750d97987acb3d1 | |
| Drug | 2-[amino-[(2R,3R)-4-(benzylamino)-3-hydroxy-4-oxo-2-sulfanylbutanoyl]amino]acetic acid | 4.14e-06 | 11 | 246 | 4 | CID016122531 | |
| Drug | 2-[amino-[(2R,3R)-4-benzoxy-3-hydroxy-4-keto-2-mercapto-butanoyl]amino]acetic acid | 6.15e-06 | 12 | 246 | 4 | CID016122530 | |
| Drug | Methotrexate [59-05-2]; Down 200; 8.8uM; HL60; HG-U133A | NEK1 PIK3CD G3BP2 KIF2A RANBP3 KIF20A CCNF STC2 TPX2 MTREX SZRD1 | 7.08e-06 | 189 | 246 | 11 | 2041_DN |
| Drug | Bisoprolol fumarate; Up 200; 9uM; HL60; HT_HG-U133A | DNAJB12 LIN7C EPB41L4A NEK1 PIK3CD G3BP2 ZEB1 POLDIP3 RFXAP CDH6 SZRD1 | 1.05e-05 | 197 | 246 | 11 | 1287_UP |
| Disease | Fanconi Anemia | 4.42e-05 | 25 | 236 | 4 | C0015625 | |
| Disease | Acute monocytic leukemia | 5.19e-05 | 26 | 236 | 4 | C0023465 | |
| Disease | Mohr Syndrome | 6.37e-05 | 2 | 236 | 2 | C0026363 | |
| Disease | ductal carcinoma in situ (biomarker_via_orthology) | 6.37e-05 | 2 | 236 | 2 | DOID:0060074 (biomarker_via_orthology) | |
| Disease | Hereditary site-specific ovarian cancer syndrome | 6.37e-05 | 2 | 236 | 2 | C4749652 | |
| Disease | Miller Dieker syndrome | 8.10e-05 | 29 | 236 | 4 | C0265219 | |
| Disease | Congenital abnormality of respiratory system | 1.90e-04 | 3 | 236 | 2 | C0035238 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.32e-04 | 152 | 236 | 7 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Bone marrow hypocellularity | 3.77e-04 | 18 | 236 | 3 | C1855710 | |
| Disease | Hereditary breast ovarian cancer syndrome | 3.78e-04 | 4 | 236 | 2 | cv:C0677776 | |
| Disease | Adams-Oliver syndrome | 3.78e-04 | 4 | 236 | 2 | cv:C0265268 | |
| Disease | Sotos' syndrome | 3.78e-04 | 4 | 236 | 2 | C0175695 | |
| Disease | granzyme b measurement | 3.78e-04 | 4 | 236 | 2 | EFO_0020418 | |
| Disease | Malignant neoplasm of breast | XIRP1 CEP85L TRPC4 BRCA1 BRCA2 G3BP2 GOLIM4 UTP20 RASAL2 FNDC3B ZEB1 B4GAT1 UBR4 DEPP1 SIK3 SETD2 STC2 GZMB GGA1 ENPEP | 4.32e-04 | 1074 | 236 | 20 | C0006142 |
| Disease | Leukemia, Myelocytic, Acute | 5.07e-04 | 173 | 236 | 7 | C0023467 | |
| Disease | chronic granulomatous disease (implicated_via_orthology) | 6.27e-04 | 5 | 236 | 2 | DOID:3265 (implicated_via_orthology) | |
| Disease | hereditary breast ovarian cancer syndrome (is_implicated_in) | 6.27e-04 | 5 | 236 | 2 | DOID:5683 (is_implicated_in) | |
| Disease | anorexia nervosa, gastroesophageal reflux disease | 6.27e-04 | 5 | 236 | 2 | EFO_0003948, MONDO_0005351 | |
| Disease | Loeys-Dietz Syndrome, Type 1a | 6.27e-04 | 5 | 236 | 2 | C4551955 | |
| Disease | Loeys-Dietz Aortic Aneurysm Syndrome | 6.27e-04 | 5 | 236 | 2 | C1836635 | |
| Disease | age at menopause | 7.77e-04 | 302 | 236 | 9 | EFO_0004704 | |
| Disease | intraocular pressure measurement | PRTG ABCA1 GAB2 DLC1 KMT2A TTF2 FNDC3B PCLO TGFB2 SH3PXD2A ZNF516 FOXP1 | 8.82e-04 | 509 | 236 | 12 | EFO_0004695 |
| Disease | HDL cholesterol change measurement | 9.03e-04 | 24 | 236 | 3 | EFO_0007805 | |
| Disease | Small cell carcinoma of lung | 9.22e-04 | 54 | 236 | 4 | C0149925 | |
| Disease | Adams Oliver syndrome | 9.35e-04 | 6 | 236 | 2 | C0265268 | |
| Disease | Congenital defect of skull and scalp | 9.35e-04 | 6 | 236 | 2 | C2931779 | |
| Disease | Adams-Oliver syndrome 1 | 9.35e-04 | 6 | 236 | 2 | C4551482 | |
| Disease | Adult only | 9.35e-04 | 6 | 236 | 2 | C3842001 | |
| Disease | Adams-Oliver syndrome (is_implicated_in) | 9.35e-04 | 6 | 236 | 2 | DOID:0060227 (is_implicated_in) | |
| Disease | Antiglaucoma preparations and miotics use measurement | 1.15e-03 | 26 | 236 | 3 | EFO_0009944 | |
| Disease | Pancytopenia | 1.15e-03 | 26 | 236 | 3 | C0030312 | |
| Disease | Loeys-Dietz Syndrome | 1.30e-03 | 7 | 236 | 2 | C2697932 | |
| Disease | Cholangitis | 1.30e-03 | 7 | 236 | 2 | C0008311 | |
| Disease | colorectal cancer (is_marker_for) | 1.70e-03 | 157 | 236 | 6 | DOID:9256 (is_marker_for) | |
| Disease | cytochrome c oxidase assembly factor 3 homolog, mitochondrial measurement | 1.73e-03 | 8 | 236 | 2 | EFO_0801513 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 1.73e-03 | 8 | 236 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | Epileptic encephalopathy | 1.75e-03 | 30 | 236 | 3 | C0543888 | |
| Disease | Breast Cancer, Familial | 1.75e-03 | 30 | 236 | 3 | C0346153 | |
| Disease | MYELODYSPLASTIC SYNDROME | 2.06e-03 | 67 | 236 | 4 | C3463824 | |
| Disease | cytochrome c oxidase subunit 4 isoform 2, mitochondrial measurement | 2.21e-03 | 9 | 236 | 2 | EFO_0801514 | |
| Disease | Pancreatic carcinoma, familial | 2.21e-03 | 9 | 236 | 2 | C2931038 | |
| Disease | choroid plexus volume measurement | 2.21e-03 | 9 | 236 | 2 | EFO_0010293 | |
| Disease | RNA-binding protein 24 measurement | 2.21e-03 | 9 | 236 | 2 | EFO_0802030 | |
| Disease | Glaucoma | 2.21e-03 | 9 | 236 | 2 | C0017601 | |
| Disease | Abnormality of radial ray | 2.31e-03 | 33 | 236 | 3 | C4228778 | |
| Disease | DNA-directed RNA polymerases I and III subunit RPAC1 measurement | 2.75e-03 | 10 | 236 | 2 | EFO_0801535 | |
| Disease | response to carboplatin, response to antineoplastic agent | 2.75e-03 | 10 | 236 | 2 | GO_0097327, GO_0097328 | |
| Disease | Fanconi anemia (is_implicated_in) | 2.75e-03 | 10 | 236 | 2 | DOID:13636 (is_implicated_in) | |
| Disease | Testicular Germ Cell Tumor | 2.82e-03 | 73 | 236 | 4 | EFO_1000566 | |
| Disease | obsolete_red blood cell distribution width | RC3H1 HEMGN F8 NSD3 FZR1 ANLN G3BP2 PLCL2 AFDN CDYL BMP8A STX7 DOCK6 FNDC3B SIK3 CCNA2 CCNF METTL25B ZNF516 GKAP1 RBM6 | 2.84e-03 | 1347 | 236 | 21 | EFO_0005192 |
| Disease | colorectal cancer (is_implicated_in) | 2.94e-03 | 121 | 236 | 5 | DOID:9256 (is_implicated_in) | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 2.97e-03 | 36 | 236 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | intellectual disability (implicated_via_orthology) | 3.11e-03 | 75 | 236 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | Aortic Valve Insufficiency | 3.34e-03 | 11 | 236 | 2 | C0003504 | |
| Disease | guanylate-binding protein 6 measurement | 3.34e-03 | 11 | 236 | 2 | EFO_0801662 | |
| Disease | neutropenia, response to gemcitabine | 3.34e-03 | 11 | 236 | 2 | GO_0036272, MONDO_0001475 | |
| Disease | Intellectual Disability | 3.39e-03 | 447 | 236 | 10 | C3714756 | |
| Disease | t-tau measurement | 3.50e-03 | 126 | 236 | 5 | EFO_0004760 | |
| Disease | non-alcoholic fatty liver disease | 3.55e-03 | 182 | 236 | 6 | EFO_0003095 | |
| Disease | thyroid carcinoma | 3.73e-03 | 39 | 236 | 3 | EFO_0002892 | |
| Disease | rheumatoid arthritis (implicated_via_orthology) | 3.99e-03 | 12 | 236 | 2 | DOID:7148 (implicated_via_orthology) | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 3.99e-03 | 12 | 236 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | rheumatic heart disease (biomarker_via_orthology) | 3.99e-03 | 12 | 236 | 2 | DOID:0050827 (biomarker_via_orthology) | |
| Disease | wellbeing measurement | SIPA1L3 TRPC4 CHD2 SLC12A5 NEK1 CNTNAP5 PLCL2 KMT2A KIF2A PCLO SIK3 TCEANC2 FOXP1 | 4.02e-03 | 692 | 236 | 13 | EFO_0007869 |
| Disease | Carcinoma, Transitional Cell | 4.30e-03 | 41 | 236 | 3 | C0007138 | |
| Disease | Cleft palate, isolated | 4.61e-03 | 42 | 236 | 3 | C1837218 | |
| Disease | Autoimmune Diseases | 4.61e-03 | 42 | 236 | 3 | C0004364 | |
| Disease | Benign tumor of pancreas | 4.69e-03 | 13 | 236 | 2 | C0347284 | |
| Disease | bronchiolitis obliterans (is_marker_for) | 4.69e-03 | 13 | 236 | 2 | DOID:2799 (is_marker_for) | |
| Disease | FEV/FEC ratio | SPEF2 DZIP1L ARMC2 GAB2 DLC1 DST TTC7B ARHGAP31 BMP8A MGA FNDC3B FRAS1 SCAF8 TGFB2 SH3PXD2A ZNF516 CNTNAP2 FOXP1 PARD3 | 4.83e-03 | 1228 | 236 | 19 | EFO_0004713 |
| Disease | Autism Spectrum Disorders | 4.87e-03 | 85 | 236 | 4 | C1510586 | |
| Disease | Fanconi anemia | 5.44e-03 | 14 | 236 | 2 | cv:C0015625 | |
| Disease | level of Phosphatidylethanolamine (18:1_18:1) in blood serum | 5.44e-03 | 14 | 236 | 2 | OBA_2045142 | |
| Disease | Saldino-Noonan Syndrome | 5.44e-03 | 14 | 236 | 2 | C0036069 | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 5.44e-03 | 14 | 236 | 2 | C0677776 | |
| Disease | eye disease | 5.60e-03 | 45 | 236 | 3 | EFO_0003966 | |
| Disease | glycerol-3-phosphate measurement | 6.24e-03 | 15 | 236 | 2 | EFO_0010488 | |
| Disease | nasopharynx carcinoma (is_implicated_in) | 6.24e-03 | 15 | 236 | 2 | DOID:9261 (is_implicated_in) | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 6.32e-03 | 145 | 236 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 6.68e-03 | 93 | 236 | 4 | C1535926 | |
| Disease | fourth ventricle volume measurement | 7.10e-03 | 16 | 236 | 2 | EFO_0010303 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 7.10e-03 | 16 | 236 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | nasopharyngeal neoplasm | 7.47e-03 | 151 | 236 | 5 | EFO_0004252 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PPNDSRLKRQVTEEL | 116 | Q7L8C5 | |
| RRPLQAQVVLKSASP | 16 | Q6ZRM9 | |
| VITLNPPSGDERQRK | 386 | Q6PI77 | |
| KPSTLQRPQETVIRE | 1466 | P55196 | |
| PELTARPQRSVSKDQ | 206 | Q6PK04 | |
| FLKEQRVLPTPQTQA | 221 | P16452 | |
| AKELSRRQRPPSVEN | 2456 | Q9P281 | |
| PQQRPRKSDARLEQL | 141 | A0A096LP49 | |
| EIRNKDLPRVSVPNF | 296 | Q9UKL4 | |
| PSPRSVDQVKAQLRT | 51 | O43505 | |
| ESQEKQPSQRDLPRR | 111 | Q9NTK1 | |
| RTQRPFTPQEAQRKL | 41 | Q8NEN0 | |
| TRAVQPLRLPSNKAQ | 121 | P10144 | |
| EQERTQQFIPVKRPI | 81 | P20718 | |
| PPQRKQNTADILQDL | 1486 | O95477 | |
| IDEQPKPLTDSQRVR | 241 | Q9UL18 | |
| QGEPQSKSPQESRRL | 1756 | Q92793 | |
| RLEQLVQEQLKSPPS | 181 | Q9HB09 | |
| LPLSNPVQKDSREEN | 96 | Q5VSY0 | |
| QSLSQRLQREFVPKP | 646 | Q8N283 | |
| RLQREFVPKPEAQVQ | 651 | Q8N283 | |
| LVVKPRRQSENISAP | 2391 | Q8TDJ6 | |
| PASERSKRQVLRSPQ | 1181 | Q96M86 | |
| PPQEDTRAQRQRLQK | 236 | O60826 | |
| NSPVRPVAKVLRNES | 861 | Q9UKL3 | |
| EKQRNPEVIPTAAAR | 201 | A6NI87 | |
| TVVVSAPNQPRQKIR | 596 | Q9P241 | |
| IKRNPEARLDPPTQQ | 186 | P56880 | |
| LPEQLLSAPKQRVNV | 61 | Q5T7V8 | |
| QQQSPRRVAVPVLVK | 251 | P43699 | |
| SQKPKEQQRSVLRPA | 161 | Q9H6Z4 | |
| EQQRSVLRPAVLQAP | 166 | Q9H6Z4 | |
| VVQRLEPRFPQASKT | 226 | Q5TC82 | |
| PRNKPSQTIRTVQAK | 1446 | Q2KHR3 | |
| EIQEAKAPSPSINRQ | 116 | Q9UJ41 | |
| SPTQVNNSIKPLRER | 396 | Q9NWS1 | |
| LQAVRPQAQDKRPAV | 251 | A6NKC0 | |
| PKERSAQPKRLNSLQ | 56 | Q96N11 | |
| AQPVDRVKRPSPESQ | 1281 | Q9HCM3 | |
| NPKAVPRLRRDTQQG | 146 | Q6ZNF0 | |
| SEGDRVQRVSLQPPK | 621 | Q8IYY4 | |
| NVQPSSKRARIEDVP | 841 | Q6ZW49 | |
| RREASDQKAPRGQQP | 396 | Q86V59 | |
| AVPIRVNPRVSNVKS | 396 | P33991 | |
| LIPQRKSRTPENQQF | 446 | A5A3E0 | |
| TTNPNQRLPKVEILR | 111 | P13349 | |
| SINITIERKNDEPPR | 1946 | Q86XX4 | |
| PPQKLQALQRVLQSE | 31 | Q9NUP9 | |
| TENVSRTRKPLARPN | 856 | Q66K74 | |
| KQEQPSRNSSLLEPQ | 126 | Q6P0N0 | |
| PPRNVTLLQERANKL | 406 | Q96JG8 | |
| SQLFKRNPRDRPSVN | 236 | Q96PY6 | |
| RNPRDRPSVNSILEK | 241 | Q96PY6 | |
| RNTAQQATRVPTPKR | 186 | A0A1B0GTS1 | |
| VPPVSRKAKSQNRQA | 891 | Q8IWI9 | |
| KQIQTSPVPVRKNSR | 571 | Q9NRM7 | |
| IFQNKEPLIRPTASQ | 601 | P59045 | |
| LQAVSPQAQDKRPAV | 251 | Q86YD7 | |
| RIEQQLPKEQALSPR | 3111 | Q03001 | |
| LSEPIAVDPKNLQRQ | 4071 | Q03001 | |
| RTPIITPNTKAIQER | 396 | Q9NQW6 | |
| LARDQFRKNPSPNIV | 336 | Q8IYD8 | |
| AELRQQLQAKPRPEE | 1296 | Q9BY66 | |
| EEKPSNRNLPTVRVD | 146 | Q8N187 | |
| DNRSNKRTPVQRTPL | 361 | Q13409 | |
| PSVVRLEKLQQQPRE | 311 | Q53TS8 | |
| KQSPQLEVRVQAPVS | 191 | Q6DN72 | |
| LQASRPQAQDKRPAV | 251 | A8MWA6 | |
| REKERSPSPQQQQSE | 101 | A6NNH2 | |
| VSRPDQNSDLQIRPV | 101 | Q6Q8B3 | |
| KLPLQRDASRPQTKQ | 271 | Q9Y6V0 | |
| PVNISASFRRKQPQE | 376 | Q8NBM8 | |
| LTRQPAPLSQKQRSF | 26 | Q9HCM2 | |
| TQIRIKVTDANDNPP | 226 | Q9Y5G2 | |
| VANPNQRLPKVEILR | 121 | P23409 | |
| ELQANLPPTKQARVI | 61 | Q9BY49 | |
| QVSPRDRPSINSILK | 241 | Q6P3R8 | |
| QSKLNQIFEITIRPP | 771 | Q9Y2G0 | |
| ASSRIEKPRAPLNQE | 221 | Q6ZU69 | |
| RNDKQPALQVPVSVA | 86 | Q9H334 | |
| RTQSREPRQQEEKPL | 326 | P25021 | |
| QSPKPKRQREAEAQQ | 391 | E9PQR5 | |
| RESPVPKVRAIQRQQ | 926 | Q9UJF2 | |
| KQVTASVRNRDPPEI | 26 | O95600 | |
| RAQELTLQTPAKRPL | 461 | Q6B0I6 | |
| LVLDNNSVRLQPPKQ | 201 | Q969V5 | |
| LERPQDRDTPVQNKR | 336 | P30305 | |
| VQNKRRRSVTPPEEQ | 346 | P30305 | |
| NPQPRTATRTQQEKL | 341 | Q96MY7 | |
| TFNQVVKPRVNSLRP | 186 | Q92917 | |
| VPELQSKVRDPRANF | 241 | O43766 | |
| KQQPTPRLTLRDLQN | 446 | Q9UJY5 | |
| RLSAERSQKATPQVP | 871 | Q9BSJ2 | |
| RRPPQTIKSVRQAFD | 106 | Q6ZNW5 | |
| SQNPPVLKRHQREIT | 1656 | P00451 | |
| EEKRNPQVVQTSPRH | 206 | Q96FB5 | |
| TQKRFLLDPRANPSQ | 556 | Q07075 | |
| AVKDINDNPPRFSRQ | 121 | Q9Y5H7 | |
| PKASTLPRAREQQQQ | 866 | P35568 | |
| RPTQDPAKPQRVVSE | 81 | Q8N7R1 | |
| RNTAQQATRVPTPKR | 186 | A0A1B0GWH4 | |
| RQKRRGTLDQPPNQE | 831 | Q6NV74 | |
| PNTLVENTALPRQRA | 71 | Q6ZV29 | |
| RKRQQNTELKVEPQP | 76 | Q9BXL5 | |
| LEEERQTQRSKPQPA | 351 | A6NI72 | |
| LEEERQTQRSKPQPA | 326 | A8MVU1 | |
| QAVRVTKPNIPEAIR | 166 | O94905 | |
| NIPLVSDPKRTIAQD | 101 | Q06830 | |
| KIQVEQPQRRFTPAV | 1061 | Q2VWP7 | |
| SLRKPDPAEQQNVTQ | 246 | O00461 | |
| LIPQRKSRKPENQQF | 446 | A0JP26 | |
| LIPQRKSRTPENQQF | 446 | Q6S8J3 | |
| LPRQLPQKERQVATA | 971 | P08648 | |
| EEQASKQINPKRPRA | 691 | O00139 | |
| RNRAKRLLQSEPENP | 131 | P38398 | |
| TLEPLSNAVKRNVPR | 46 | Q86Y29 | |
| QDPKSQIRAFRDPLQ | 1006 | Q9Y2I7 | |
| KVQDPQTEDRRLQPS | 106 | Q9UM11 | |
| QLQDAVPQRPTRPSK | 66 | Q8N8I6 | |
| DRDPLQKQPSCQRSV | 621 | P49915 | |
| QTFNLPLTPRIENRK | 1151 | Q4AC94 | |
| PLTPRIENRKELRNQ | 1156 | Q4AC94 | |
| SRQQQRQEKPRLLEP | 36 | Q96BY6 | |
| PVTTDTQRERQKGLP | 136 | Q96HP0 | |
| PTSRQNVSKILPRVD | 2096 | P51587 | |
| PESSVPQQQVKRINL | 756 | P41002 | |
| QQPPALQVERIVDKR | 56 | Q9Y232 | |
| RKPNVTFRPENSIIN | 2486 | Q9H799 | |
| VVREQITRALPSKPN | 476 | Q96JJ3 | |
| RSPLERSLEQKNNPD | 1806 | O14647 | |
| PQRPLSQERRGKQSV | 426 | Q0VF96 | |
| IKRINVVPDQPSERA | 331 | Q9BPX7 | |
| PPRIANRTKNSLTLQ | 376 | Q9Y2H6 | |
| KDRQIDRQNRLNSPP | 196 | Q53EP0 | |
| KPEVQSQPPRVREQR | 281 | Q9UN86 | |
| LPQERKQAPSTRRDS | 906 | Q6ZU35 | |
| TVSPNLRPVNEKLEA | 151 | Q8IZJ3 | |
| SNQPVNPRSLEKLEI | 36 | P02778 | |
| PRVRALIESLNQKPQ | 41 | Q9NXW2 | |
| PKEVPASRLAQQLRE | 661 | Q96RY5 | |
| RQPKKSNELPQANRL | 271 | Q7Z5Y6 | |
| RPPNRNDFLNTSKVI | 46 | P0DN25 | |
| EPDQSRQQTVLSKRP | 691 | Q5SZL2 | |
| RIPVNTRFQTKIPNI | 336 | P09622 | |
| QPLRELRSNVVSPTK | 636 | Q71RC2 | |
| SNSEPVNKEQDQRPL | 141 | Q9NX58 | |
| SPRLENRNNQKPDRD | 341 | Q8NA03 | |
| EKNQRPRKQTSAPAE | 811 | Q03164 | |
| NISSLQPVRENQPTK | 201 | Q9ULL0 | |
| QPVRENQPTKARAKS | 206 | Q9ULL0 | |
| QLSPRQLSQALRKPE | 1291 | Q9ULL0 | |
| PQRSVKAERAQQPEA | 1036 | Q76NI1 | |
| QRRSPKETVTPEQLQ | 266 | Q8WWI5 | |
| EAIPRAIINPSNRKV | 251 | Q5VU92 | |
| INQRLKENDTDPTAP | 716 | P55285 | |
| LQVDRLPQQIRKAPT | 896 | Q9UHC6 | |
| RIIVPLNNRENISDP | 61 | P01591 | |
| QQKEPSIDERPPVSR | 1326 | Q05BV3 | |
| RAQALDRLTNKPVEP | 121 | Q9ULB5 | |
| EKAAPVQQPRTRAAL | 36 | P20248 | |
| STQPKRNKRNPIFQD | 21 | Q5XKR9 | |
| TLEPLSNAVKRNVPR | 46 | Q86Y30 | |
| IRADHNTVLPKQPRQ | 341 | Q5H9B9 | |
| RQPKKSNELPQANRL | 271 | P34820 | |
| RDLSIQLPRPDQNVT | 331 | Q9HCS5 | |
| QLPRPDQNVTRSRSK | 336 | Q9HCS5 | |
| PGRQSVDNVTNPEKR | 986 | Q9UPN6 | |
| NTELTRVRGANPEKP | 636 | Q8WYK1 | |
| LQASRPQAQDKRPAV | 251 | P0C7X0 | |
| RKQQTTVPQKPRQVA | 101 | Q9BY77 | |
| PSQVARLNRLQTPEK | 1336 | Q8TEW0 | |
| RKNPANTRLRLNVPE | 966 | Q9H2X9 | |
| LQPQTTVNPDRIKQT | 136 | P51513 | |
| LIPQRRSRKPENQQF | 446 | B2RU33 | |
| LPSLQSPQERERKVA | 1006 | Q6ZUA9 | |
| SVPQRSLLEQAQKPI | 806 | Q7Z2Y5 | |
| LIPQRRSRKPENQQF | 446 | Q86YR6 | |
| DVPLVVRPKVRTQAQ | 31 | Q5JY77 | |
| RNNTVIDELPFKSPI | 531 | Q9UQC2 | |
| EQEKPILDRPTRISQ | 111 | Q7Z422 | |
| NRERKQGEQSLAPSP | 726 | Q8N1F8 | |
| SPQPTEIRIQRKKEN | 391 | O75445 | |
| PADLQVAPTQDLRRK | 856 | O75691 | |
| PQPRTAQPQKREEQT | 926 | P78332 | |
| QAAIIQIPKPASNRT | 211 | Q9C093 | |
| ADQASPRAVRIQPKV | 121 | Q9C004 | |
| IRTPRIQNSPQKKDS | 6 | Q96MN5 | |
| PSDRPLQSNDKEQLQ | 16 | Q9Y2J0 | |
| IPQETLNQINKASPR | 256 | P43307 | |
| PAQQLLKVNPTRARS | 676 | Q3ZLR7 | |
| KRNRQPLTSNPLKDD | 26 | Q8NHS9 | |
| ERPPSRVASKEQQLL | 386 | P32745 | |
| PAREEQRPIQPSFTK | 41 | Q8IW70 | |
| EQPFRDRSNTLNEKP | 1091 | Q9UMZ2 | |
| LPTTPSEQRQRKIQK | 76 | O15400 | |
| QRGQKPSQESLRVLP | 191 | Q8N3V7 | |
| RINPETDLPRKLSSQ | 861 | Q587J7 | |
| KNAQPPIRDATDLRE | 921 | Q9UPR0 | |
| RPSDDNPVRANLRTK | 606 | O14802 | |
| PPASASDLIEQQQKR | 336 | Q5VSL9 | |
| LEVPKEQQRTQSRPR | 476 | O60292 | |
| KQTEVLLQPNPNARI | 61 | Q9Y371 | |
| RLPPTEFAQLIKRQQ | 986 | Q9Y2K2 | |
| QRAASSRPIKLLQQP | 71 | Q9BYL1 | |
| LIPQRKSRTPENQQF | 446 | P0CG38 | |
| PARPTLLEQVLNQKR | 221 | O00287 | |
| RLLKSVRNSDPNDPN | 126 | Q96SB4 | |
| QPRIDQRTAISPKDA | 146 | Q8NE31 | |
| SRQELNTIASKPPRD | 296 | P11215 | |
| PNRDRQIRDQQPLKS | 1131 | P0DKV0 | |
| LNSAVIAQQRRKPDP | 226 | Q96QB1 | |
| LLQQQPEDDSKRSPR | 406 | Q9UHB9 | |
| QEPSPNLSREKTREN | 166 | Q8IY92 | |
| VQFKIRRQLPAPQDE | 186 | Q8IVF2 | |
| RAQLVQALQAEPPSR | 596 | P51800 | |
| QIENIRSPEGSRKNP | 1241 | P02452 | |
| VFRLQNPKARVPEQR | 151 | P61812 | |
| RRTENPTKNELSQSP | 2956 | A4UGR9 | |
| NRKPSPQDIAQAVLR | 2971 | Q63HN8 | |
| LKNPQTQTEERFRPQ | 5141 | Q63HN8 | |
| NEVSKRVRIPLPVSN | 831 | Q96JG6 | |
| NRPKSELDPIATINN | 306 | Q92618 | |
| ARKQAQEQLRPQTPE | 231 | Q86UC2 | |
| NPNLLPSKQQVRTRD | 61 | A8K554 | |
| SSRSDLPVIQRNPKR | 741 | Q5TAP6 | |
| IPKDLRPVDNRQSVL | 746 | P42285 | |
| PSLTKRSRAQEEQVP | 366 | Q9Y572 | |
| PLDVVKVRLQSQRPS | 31 | Q9BZJ4 | |
| RKAQRNNEDISIIPP | 116 | P51571 | |
| LLEPPSQQRKRQTLR | 316 | O95235 | |
| RQPDQIRKQESPIRE | 101 | A0A1B0GVG6 | |
| RKTKEFRSPPQEQIN | 1861 | Q15413 | |
| PFNPEKTVERVQRIS | 3441 | Q15413 | |
| VRPKPFLNRAESQSQ | 756 | Q5TCZ1 | |
| QLRLQPQEAPETETR | 441 | Q96HA7 | |
| PTRIRQIIDKDRQPQ | 1486 | Q6ZQQ2 | |
| APPERQPQVDRTKLS | 221 | O76061 | |
| ITARKPLPRTEPQNN | 36 | A7MD48 | |
| LQAVRPQAQDKRPAV | 251 | Q658T7 | |
| RKPRPVSQLVAQQVT | 51 | Q8IY57 | |
| RDEQSNPAPQVQKPR | 286 | O00329 | |
| KVQELQSPPRASQVV | 906 | O14795 | |
| SPRNQRKALNISEPF | 476 | Q2M1Z3 | |
| KSPRQQQFLDRVRSP | 1121 | Q9UGU0 | |
| QRNRQVATALPLEKP | 216 | Q9BXA5 | |
| DRLIISTPNQRNEKP | 541 | Q9BZ95 | |
| IPRNRLQSVVVVPKN | 1061 | Q9BYW2 | |
| TPNRSRERDPDKQTQ | 2056 | Q9BYW2 | |
| LVASNNKIRDPVSEP | 331 | Q53FD0 | |
| GSPTRPQIRQKIENK | 321 | P37275 | |
| QEKNSSNFIERRPPE | 131 | Q9UBW7 | |
| QEQPKRLPSHVSRQE | 6 | Q17R98 | |
| LQPDRLQPVEKREQA | 486 | Q96IT1 | |
| ERVILSNIQNRSPKP | 191 | Q86TV6 | |
| VSRTNNPLPLEQRID | 71 | Q9UIA9 | |
| VKRILENPQSLSDPN | 311 | Q9UIA9 | |
| LKEVEQPRPQDSNLS | 936 | Q9UPP1 | |
| PLQPVSIENRNLDLK | 1551 | Q5VWN6 | |
| LRTPRTLVEQKQNPT | 1041 | O43314 | |
| NEVNRVTLRPKSNPE | 371 | O75604 | |
| LASPVSPELRQKEVQ | 176 | Q5T4S7 | |
| NEASPVKRPRLLENT | 126 | Q9H8U3 | |
| QFIRSPQRNPTVKDL | 1171 | Q04912 | |
| RPLDAINQDPSQVRV | 276 | Q702N8 | |
| VPNPSSKRNEQRIEL | 156 | P10600 | |
| KPQDFLRLQQVSRPT | 486 | Q9H1B5 | |
| QEPPREKQRKVNFVT | 826 | Q9UBN4 | |
| SEPLREKVTQLLPQN | 251 | Q9UNY4 | |
| REERPQQSPKVQASP | 281 | Q49AM3 | |
| EAAISRKTPAQPQRR | 106 | Q9ULW0 | |
| RPVSPETQADLQRNL | 926 | Q9P206 | |
| EPQTQRPQSIARKRP | 161 | Q8N8K9 | |
| TRLQDIDPQRVRKPN | 316 | Q8N145 | |
| RSTLLNPNQRLPKVE | 106 | P15173 | |
| NPNQRLPKVEILRSA | 111 | P15173 | |
| TRQERQGPAKPEVLS | 161 | Q8N987 | |
| VRRAVKDTLSNPQSP | 466 | Q96PU5 |